Journal of Movement Disorders

Volume 8(2); May 2015

Review Articles

Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes: Ruth H. Walker; J Mov Disord. 2015;8(2):41-54. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15009

29,895 View
382 Download
43 Web of Science
38 Crossref

There have been significant advances in neuroacanthocytosis (NA) syndromes in the past 20 years, however, confusion still exists regarding the precise nature of these disorders and the correct nomenclature. This article seeks to clarify these issues and to summarise the recent literature in the field. The four key NA syndromes are described here–chorea-acanthocytosis, McLeod syndrome, Huntington’s disease-like 2, and pantothenate kinase- associated neurodegeneration. In the first two, acanthocytosis is a frequent, although not invariable, finding; in the second two, it occurs in approximately 10% of patients. Degeneration affecting the basal ganglia is the key neuropathologic finding, thus the clinical presentations can be remarkably similar. The characteristic phenotype comprises a variety of movement disorders, including chorea, dystonia, and parkinsonism, and also psychiatric and cognitive symptoms attributable to basal ganglia dysfunction. The age of onset, inheritance patterns, and ethnic background differ in each condition, providing diagnostic clues. Other investigations, including routine blood testing and neuroimaging can be informative. Genetic diagnosis, if available, provides a definitive diagnosis, and is important for genetic counseling, and hopefully molecular therapies in the future. In this article I provide a historical perspective on each NA syndrome. The first 3 disorders, chorea-acanthocytosis, McLeod syndrome, Huntington’s disease-like 2, are discussed in detail, with a comprehensive review of the literature to date for each, while pantothenate kinase-associated neurodegeneration is presented in summary, as this disorder has recently been reviewed in this journal. Therapy for all of these diseases is, at present, purely symptomatic.

Citations

Citations to this article as recorded by

Identification of four novel mutations in VSP13A in Iranian patients with Chorea-acanthocytosis (ChAc)
Vadieh Ghodsinezhad, Abdoreza Ghoreishi, Mohammad Rohani, Mahdi Dadfar, Akbar Mohammadzadeh, Ali Rostami, Hamzeh Rahimi
Molecular Genetics and Genomics.2024;[Epub] CrossRef
Case report: Misdiagnosed orolingual dyskinesia as a consequence of seizures in a chorea-acanthocytosis patient with a novel VPS13A variation from a family with consanguineous marriage
Mengying Wang, Huimin Li, Qing Zhou, Qin Zhao, Man Wang, Yumei Geng, Huicong Kang
Frontiers in Neurology.2024;[Epub] CrossRef
Supranuclear Vertical Gaze Palsy in Movement Disorders
Mehri Salari, Alireza Alikhani, Fatemeh Hojjati Pour, Masoud Etemadifar
Neuro-Ophthalmology.2024; : 1. CrossRef
A case of chorea-acanthocytosis with significant improvement of symptoms at one year with deep brain stimulation: case report and literature review
Yan Xu, Jiabin Yu, Yimeng Gao, Qiaozhen Su, Haitao Xie, Hongfeng Liang, Chunye Zheng
Frontiers in Neurology.2024;[Epub] CrossRef
Early Onset Parkinsonism: Differential diagnosis and what not to miss
Norlinah Mohamed Ibrahim, Chin Hsien Lin
Parkinsonism & Related Disorders.2024; 129: 107100. CrossRef
Exploring the pathophysiological mechanisms and wet biomarkers of VPS13A disease
Jingqi Lin, Hongmei Meng, Nilupaer Shafeng, Jiaai Li, Huaiyu Sun, Xi Yang, Zhiqing Chen, Shuai Hou
Frontiers in Neurology.2024;[Epub] CrossRef
Acupuncture for treating symptoms associated with chorea-acanthocytosis: A CARE-compliant case report
Qiqi Wu, Zengtu Li, Yingying Cheng, Hantong Hu, Hong Gao, Jiawei Wang, Dexiong Han
EXPLORE.2023; 19(1): 127. CrossRef
Two case reports of chorea-acanthocytosis and review of literature
Shuangfeng Huang, Junliang Zhang, Manli Tao, Yaodong Lv, Luyao Xu, Zhigang Liang
European Journal of Medical Research.2022;[Epub] CrossRef
Skin Conditions and Movement Disorders: Hiding in Plain Sight
Kristina Kulcsarova, Janette Baloghova, Jan Necpal, Matej Skorvanek
Movement Disorders Clinical Practice.2022; 9(5): 566. CrossRef
The XK plasma membrane scramblase and the VPS13A cytosolic lipid transporter for ATP‐induced cell death
Yuta Ryoden, Shigekazu Nagata
BioEssays.2022;[Epub] CrossRef
Pallidus Stimulation for Chorea-Acanthocytosis: A Systematic Review and Meta-Analysis of Individual Data
Weibin He, Chenhui Li, Hongjuan Dong, Lingmin Shao, Bo Yin, Dianyou Li, Liguo Ye, Ping Hu, Chencheng Zhang, Wei Yi
Journal of Movement Disorders.2022; 15(3): 197. CrossRef
Chorea-acanthocytosis: Time-dependent changes of symptoms and imaging findings
Fumio Suzuki, Noriko Sato, Atsuhiko Sugiyama, Keiya Iijima, Yoko Shigemoto, Emiko Morimoto, Yukio Kimura, Hiroyuki Fujii, Yuji Takahashi, Yasuhiro Nakata, Hiroshi Matsuda, Osamu Abe
Journal of Neuroradiology.2021; 48(6): 419. CrossRef
Prionopathies and Prionlike Protein Aberrations in Neurodegenerative Diseases
K.N. Anderson, W.B. Overcast, J.R. Brosch, B.D. Graner, M.C. Veronesi
Neurographics.2021; 11(2): 127. CrossRef
Brain F-18 FDG and F-18 FP-CIT PET/CT Findings of c.856_860delCTCTA Mutation McLeod Syndrome
Ho-Sung Ryu, Chae Moon Hong
Cognitive and Behavioral Neurology.2021; 34(3): 207. CrossRef
Vacuolar Protein-Sorting Receptor MoVps13 Regulates Conidiation and Pathogenicity in Rice Blast Fungus Magnaporthe oryzae
Xueming Zhu, Lin Li, Jiaoyu Wang, Lili Zhao, Huanbin Shi, Jiandong Bao, Zhenzhu Su, Xiaohong Liu, Fucheng Lin
Journal of Fungi.2021; 7(12): 1084. CrossRef
Involuntary movements, vocalizations and cognitive decline
Olafur Sveinsson, Bjarne Udd, Per Svenningsson, Christoph Gassner, Charlotte Engström, José Laffita-Mesa, Göran Solders, Stellan Hertegård, Irina Savitcheva, Hans H. Jung, Markus Tolnay, Beat M. Frey, Martin Paucar
Parkinsonism & Related Disorders.2020; 79: 135. CrossRef
Discriminating chorea-acanthocytosis from Huntington's disease with single-case voxel-based morphometry analysis
Fumio Suzuki, Noriko Sato, Miho Ota, Atsuhiko Sugiyama, Yoko Shigemoto, Emiko Morimoto, Yukio Kimura, Noritaka Wakasugi, Yuji Takahashi, Akinori Futamura, Mitsuru Kawamura, Kenjiro Ono, Masayuki Nakamura, Akira Sano, Masako Watanabe, Hiroshi Matsuda, Osam
Journal of the Neurological Sciences.2020; 408: 116545. CrossRef
Identification of two compound heterozygous VPS13A large deletions in chorea‐acanthocytosis only by protein and quantitative DNA analysis
Derek Spieler, Antonio Velayos‐Baeza, Alžbeta Mühlbäck, Florian Castrop, Christian Maegerlein, Julia Slotta‐Huspenina, Benedikt Bader, Bernhard Haslinger, Adrian Danek
Molecular Genetics & Genomic Medicine.2020;[Epub] CrossRef
Neuroacanthocytosis with unusual clinical features
Hui Zhu, Xue-min Feng, Teng Zhao, Jing-yao Liu
Medicine.2019; 98(2): e14050. CrossRef
VPS13A, a closely associated mitochondrial protein, is required for efficient lysosomal degradation
Sandra Muñoz-Braceras, Alba R. Tornero-Écija, Olivier Vincent, Ricardo Escalante
Disease Models & Mechanisms.2019;[Epub] CrossRef
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
Nicki Niemann, Joseph Jankovic
Parkinsonism & Related Disorders.2019; 67: 74. CrossRef
Chorea
Pichet Termsarasab
CONTINUUM: Lifelong Learning in Neurology.2019; 25(4): 1001. CrossRef
Neuroacanthocytosis: a case report of chorea-acanthocytosis
Yuanyuan Xiang, Shan Li, Xiaohui Liu, Jifeng, Li, Qinjian, Sun, Yan, Chen, Yifeng Du, Junwei Wu
Journal of Integrative Neuroscience.2019;[Epub] CrossRef
Chorea-acanthocytosis
Susan Walker, Rubina Dad, Bhooma Thiruvahindrapuram, Muhammed Ikram Ullah, Arsalan Ahmad, Muhammad Jawad Hassan, Stephen W. Scherer, Berge A. Minassian
Neurology Genetics.2018;[Epub] CrossRef
Huntington's disease-like disorders in Latin America and the Caribbean
Ruth H. Walker, Emilia M. Gatto, M. Leonor Bustamante, Oscar Bernal-Pacheco, Francisco Cardoso, Raphael M. Castilhos, Pedro Chana-Cuevas, Mario Cornejo-Olivas, Ingrid Estrada-Bellmann, Laura B. Jardim, Ricardo López-Castellanos, Ricardo López-Contreras, D
Parkinsonism & Related Disorders.2018; 53: 10. CrossRef
Feeding Dystonia
Ritu Shree, Sahil Mehta, Venugopalan Y. Vishnu
Movement Disorders Clinical Practice.2018; 5(4): 442. CrossRef
Comment on: Consequences of Delayed Dental Extraction in Lesch‐Nyhan Disease
Harriet Van Den Tooren, Benjamin M. Davies, Monty Silverdale, David McKee
Movement Disorders Clinical Practice.2017; 4(3): 463. CrossRef
Novel VPS13A Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review
Yan Shen, Xiaoming Liu, Xi Long, Chao Han, Fang Wan, Wenliang Fan, Xingfang Guo, Kai Ma, Shiyi Guo, Luxi Wang, Yun Xia, Ling Liu, Jinsha Huang, Zhicheng Lin, Nian Xiong, Tao Wang
Frontiers in Aging Neuroscience.2017;[Epub] CrossRef
Stepwise partitioning of Xp21: a profiling method for XK deletions causative of the McLeod syndrome
Christoph Gassner, Chantal Brönnimann, Yvonne Merki, Maja P. Mattle‐Greminger, Sonja Sigurdardottir, Eduardo Meyer, Charlotte Engström, John D. O'Sullivan, Hans H. Jung, Beat M. Frey
Transfusion.2017; 57(9): 2125. CrossRef
Disruption of GABA(A)-mediated intracortical inhibition in patients with chorea-acanthocytosis
Raffaele Dubbioso, Marcello Esposito, Silvio Peluso, Rosa Iodice, Giuseppe De Michele, Lucio Santoro, Fiore Manganelli
Neuroscience Letters.2017; 654: 107. CrossRef
The First Genetically Confirmed McLeod Syndrome in Korea
Kye Won Park, Soo Jeong, Eul-Ju Seo, Chong S. Lee
Journal of the Korean Neurological Association.2017; 35(2): 85. CrossRef
Hippocampal sclerosis and mesial temporal lobe epilepsy in chorea‐acanthocytosis: a case with clinical, pathologic and genetic evaluation
K. Mente, S. A. Kim, C. Grunseich, M. M. Hefti, J. F. Crary, A. Danek, B. I. Karp, R. H. Walker
Neuropathology and Applied Neurobiology.2017; 43(6): 542. CrossRef
Yeast and other lower eukaryotic organisms for studies of Vps13 proteins in health and disease
Weronika Rzepnikowska, Krzysztof Flis, Sandra Muñoz‐Braceras, Regina Menezes, Ricardo Escalante, Teresa Zoladek
Traffic.2017; 18(11): 711. CrossRef
Peripheral neuropathy in complex inherited diseases: an approach to diagnosis
Alexander M Rossor, Aisling S Carr, Helen Devine, Hoskote Chandrashekar, Ana Lara Pelayo-Negro, Davide Pareyson, Michael E Shy, Steven S Scherer, Mary M Reilly
Journal of Neurology, Neurosurgery & Psychiatry.2017; 88(10): 846. CrossRef
Huntington's Disease, Huntington's Disease Look‐Alikes‎, and Benign Hereditary Chorea: What's New?
Susanne A. Schneider, Thomas Bird
Movement Disorders Clinical Practice.2016; 3(4): 342. CrossRef
Clinical Heterogeneity of Atypical Pantothenate Kinase-Associated Neurodegeneration in Koreans
Jae-Hyeok Lee, Jongkyu Park, Ho-Sung Ryu, Hyeyoung Park, Young Eun Kim, Jin Yong Hong, Sang Ook Nam, Young-Hee Sung, Seung-Hwan Lee, Jee-Young Lee, Myung Jun Lee, Tae-Hyoung Kim, Chul Hyoung Lyoo, Sun Ju Chung, Seong Beom Koh, Phil Hyu Lee, Jin Whan Cho,
Journal of Movement Disorders.2016; 9(1): 20. CrossRef
Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach
Davide Tonduti, Luisa Chiapparini, Isabella Moroni, Anna Ardissone, Giovanna Zorzi, Federica Zibordi, Sergio Raspante, Celeste Panteghini, Barbara Garavaglia, Nardo Nardocci
Current Neurology and Neuroscience Reports.2016;[Epub] CrossRef
Clinical variability of neuroacanthocytosis syndromes—a series of six patients with long follow-up
J. Dulski, W. Sołtan, M. Schinwelski, M. Rudzińska, M. Wójcik-Pędziwiatr, L. Wictor, F. Schön, A. Puschmann, J. Klempíř, L. Tilley, J. Roth, P. Tacik, S. Fujioka, W. Drozdowski, E.J. Sitek, Z. Wszolek, J. Sławek
Clinical Neurology and Neurosurgery.2016; 147: 78. CrossRef

¹²³I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review: Eun Joo Chung, Sang Jin Kim; J Mov Disord. 2015;8(2):55-66. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15015

19,857 View
210 Download
48 Web of Science
46 Crossref

Abstract PDF

Lewy body-related disorders are characterized by the presence of Lewy bodies and Lewy neurites, which have abnormal aggregations of α-synuclein in the nigral and extranigral areas, including in the heart. 123I-metaiodobenzylguanidine (MIBG) scintigraphy is a well-known tool to evaluate cardiac sympathetic denervation in the Lewy body-related disorders. MIBG scintigraphy showed low uptake of MIBG in the Lewy body-related disorders, including Parkinson’s disease, dementia with Lewy bodies, pure autonomic failure and rapid eye movement sleep behavior disorder. This review summarizes previous results on the diagnostic applications of MIBG scintigraphy in Lewy body-related disorders.

Citations

Citations to this article as recorded by

Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study
Keita Sakurai, Aya M. Tokumaru, Mari Yoshida, Yuko Saito, Koichi Wakabayashi, Takashi Komori, Masato Hasegawa, Takeshi Ikeuchi, Yuichi Hayashi, Takayoshi Shimohata, Shigeo Murayama, Yasushi Iwasaki, Toshiki Uchihara, Motoko Sakai, Ichiro Yabe, Satoshi Tan
Neuroradiology.2024; 66(11): 1917. CrossRef
Blunted tachycardia and cardiac sympathetic denervation in isolated rapid eye movement sleep behavior disorder
Shota Saeda, Yukiyoshi Sumi, Koichi Fujiwara, Hiroshi Kadotani
BMC Neurology.2024;[Epub] CrossRef
Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease
Don Gueu Park, Woorim Kang, In-Ja Shin, Mauricio Chalita, Hyun-Seok Oh, Dong-Wook Hyun, Hyun Kim, Jongsik Chun, Young-Sil An, Eun Jeong Lee, Jung Han Yoon
Neurobiology of Disease.2024; 201: 106655. CrossRef
Sudden cardiac death in synucleinopathies
Keivan Javanshiri, Tove Drakenberg, Mattias Haglund, Elisabet Englund
Journal of Neuropathology & Experimental Neurology.2023; 82(3): 242. CrossRef
Optimal Protocol and Clinical Usefulness of 123I-MIBG Cardiac Scintigraphy for Differentiation of Parkinson’s Disease and Dementia with Lewy Body from Non-Parkinson’s Diseases
In Kook Chun
Nuclear Medicine and Molecular Imaging.2023; 57(3): 145. CrossRef
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Brain Sciences.2023; 13(10): 1471. CrossRef
Differentiating Dementia with Lewy Bodies from Alzheimer's Disease Using the Fall Risk Evaluation Questionnaire
Masashi Tsujimoto, Keisuke Suzuki, Akinori Takeda, Naoki Saji, Takashi Sakurai, Yukihiko Washimi
Internal Medicine.2022; 61(11): 1687. CrossRef
Association of plasma α-synuclein with cardiac 123I-MIBG scintigraphy in early Parkinson’s disease
Don Gueu Park, Juhee Kang, Young-Sil An, Jaerak Chang, Jung Han Yoon
Neuroscience Letters.2022; 770: 136399. CrossRef
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease.2022; 164: 105626. CrossRef
Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies
Keivan Javanshiri, Tove Drakenberg, Mattias Haglund, Elisabet Englund
Journal of Parkinson's Disease.2022; 12(4): 1125. CrossRef
Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age
G. Roberts, J.J. Lloyd, J.P.M. Kane, R. Durcan, S. Lawley, K. Howe, G.S. Petrides, J.T. O’Brien, A.J. Thomas
Journal of Nuclear Cardiology.2021; 28(4): 1692. CrossRef
Uniformity of cardiac 123I-MIBG uptake on SPECT images in older adults with normal cognition and patients with dementia
Gemma Roberts, Jim J. Lloyd, Elizabeth Jefferson, Joseph P.M. Kane, Rory Durcan, Sarah Lawley, George S. Petrides, Kim Howe, Iftikhar Haq, John T. O’Brien, Alan J. Thomas
Journal of Nuclear Cardiology.2021; 28(5): 2151. CrossRef
Myocardial Sympathetic Innervation Imaging with MIBG in Dementia with Lewy Bodies
Gagandeep Choudhary, Pradeep Bhambhvani
Journal of Nuclear Cardiology.2021; 28(5): 2164. CrossRef
Identification of BAG2 and Cathepsin D as Plasma Biomarkers for Parkinson’s Disease
Juhee Kang, Jae Whan Kim, Hansol Heo, Jihyun Lee, Kwan Yong Park, Jung Han Yoon, Jaerak Chang
Clinical and Translational Science.2021; 14(2): 606. CrossRef
Gastrointestinal Dysfunction in Parkinson’s Disease
Casper Skjærbæk, Karoline Knudsen, Jacob Horsager, Per Borghammer
Journal of Clinical Medicine.2021; 10(3): 493. CrossRef
Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson’s Disease—a Systematic Review
Vasiliki Katsi, Ilias Papakonstantinou, Eirini Solomou, Alexios S. Antonopoulos, Charalambos Vlachopoulos, Konstantinos Tsioufis
Current Hypertension Reports.2021;[Epub] CrossRef
Lewy Body Dementias: A Coin with Two Sides?
Ángela Milán-Tomás, Marta Fernández-Matarrubia, María Cruz Rodríguez-Oroz
Behavioral Sciences.2021; 11(7): 94. CrossRef
Cardiac Autonomic Dysfunction Is Associated with Severity of REM Sleep without Atonia in Isolated REM Sleep Behavior Disorder
Sooyeoun You, Kyoung Sook Won, Keun Tae Kim, Hyang Woon Lee, Yong Won Cho
Journal of Clinical Medicine.2021; 10(22): 5414. CrossRef
A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index
Fumi Sakamoto, Shinya Shiraishi, Koji Ogasawara, Noriko Tsuda, Masataka Nakagawa, Seiji Tomiguchi, Yasuyuki Yamashita
Annals of Nuclear Medicine.2020; 34(6): 415. CrossRef
Difference in cardiovascular response during orthostatic stress in Parkinson’s disease and multiple system atrophy
Tomohiko Nakamura, Masashi Suzuki, Masamichi Ueda, Yumiko Harada, Masaaki Hirayama, Masahisa Katsuno
Journal of Neural Transmission.2020; 127(10): 1377. CrossRef
Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease
Yoon-Sang Oh, Joong-Seok Kim, Sang-Won Yoo, Eo-Jin Hwang, Chul Hyoung Lyoo, Kwang-Soo Lee
Parkinsonism & Related Disorders.2019; 63: 156. CrossRef
Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes
Dong-Woo Ryu, Joong-Seok Kim, Jee-Eun Lee, Yoon-Sang Oh, Sang-Won Yoo, Ie Ryung Yoo, Kwang-Soo Lee
Clinical Nuclear Medicine.2019; 44(4): 282. CrossRef
Cardiac 123I-MIBG planar heart to mediastinum ratios depend on patient size; phantom studies suggest SPECT-CT could improve quantification
Gemma Roberts, Jim J Lloyd, George S Petrides, John T O’Brien, Alan J Thomas
Biomedical Physics & Engineering Express.2019; 6(1): 015011. CrossRef
Does sympathetic dysfunction occur before denervation in pure autonomic failure?
Ling Guo, Murray D. Esler, Carolina Sari, Sarah Phillips, Elisabeth A. Lambert, Nora E. Straznicky, Gavin W. Lambert, Susan J. Corcoran
Clinical Science.2018; 132(1): 1. CrossRef
Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study
Dan Xu, Wenjia Zhu, Li Huo, Shikun Zhu, Fang Li, Han Wang
Parkinsonism & Related Disorders.2018;[Epub] CrossRef
Extensive Delayed Brain Atrophy after Resuscitation in a Patient with Multiple System Atrophy
Sazuku Nisitani, Hirofumi Miyoshi, Yoji Katsuoka
Frontiers in Neurology.2018;[Epub] CrossRef
Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm
J. William Langston, Jesse C. Wiley, Michele Tagliati
npj Parkinson's Disease.2018;[Epub] CrossRef
Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
Ilaria Cova, Alberto Priori
Journal of Neural Transmission.2018; 125(10): 1417. CrossRef
Imaging the Autonomic Nervous System in Parkinson’s Disease
Karoline Knudsen, Per Borghammer
Current Neurology and Neuroscience Reports.2018;[Epub] CrossRef
A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment
Samuel D. Capouch, Martin R. Farlow, Jared R. Brosch
Neurology and Therapy.2018; 7(2): 249. CrossRef
The Utility of the Combined Use of ¹²³I-FP-CIT and ¹²³I-MIBG Myocardial Scintigraphy in Differentiating Parkinson’s Disease from Other Parkinsonian Syndromes
Eiji Matsusue, Yoshio Fujihara, Kenichiro Tanaka, Yuki Aozasa, Manabu Shimoda, Hiroyuki Nakayasu, Kazuhiko Nakamura, Toshihide Ogawa
Yonago Acta Medica.2018; 61(2): 117. CrossRef
Correction of collimator-dependent differences in the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging
Yusuke Inoue, Yutaka Abe, Kei Kikuchi, Keiji Matsunaga, Ray Masuda, Kazutoshi Nishiyama
Journal of Nuclear Cardiology.2017; 24(5): 1725. CrossRef
Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
J.‐S. Kim, H.‐E. Park, I.‐S. Park, Y.‐S. Oh, D.‐W. Ryu, I.‐U. Song, Y.‐A. Jung, I. R. Yoo, H.‐S. Choi, P. H. Lee, K.‐S. Lee
European Journal of Neurology.2017; 24(2): 349. CrossRef
Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features?
Fumi Sakamoto, Shinya Shiraishi, Noriko Tsuda, Mamoru Hashimoto, Seiji Tomiguchi, Manabu Ikeda, Yasuyuki Yamashita
The British Journal of Radiology.2017;[Epub] CrossRef
Imaging Parkinson’s disease below the neck
Per Borghammer, Karoline Knudsen, Tatyana D. Fedorova, David J. Brooks
npj Parkinson's Disease.2017;[Epub] CrossRef
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes
Naoto Uyama, Hideki Otsuka, Takayoshi Shinya, Yoichi Otomi, Masafumi Harada, Wataru Sako, Yuishin Izumi, Ryuji Kaji, Yuya Watanabe, Satoru Takashi, Yamato Kunikane
Nuclear Medicine Communications.2017; 38(6): 487. CrossRef
Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study
Mun Hee Choi, Jung Han Yoon, Suk Woo Yong
Journal of the Neurological Sciences.2017; 381: 291. CrossRef
Cardiovascular autonomic dysfunctions in elderly patients with essential tremor: comparison with healthy controls
Joong-Seok Kim, Yoon-Sang Oh, Hyung-Eun Park, Si-Hoon Lee, Jeong-Wook Park, In-Uk Song, Jae-Young An, Hun-Jun Park, Byung-Chul Son, Kwang-Soo Lee
Neurological Sciences.2016; 37(5): 711. CrossRef
Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder
Joong-Seok Kim, Hyung-Eun Park, Yoon-Sang Oh, Si-Hoon Lee, Jeong-Wook Park, Byung-chul Son, Kwang-Soo Lee
Journal of the Neurological Sciences.2016; 362: 59. CrossRef
[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies
J. J. van der Zande, J. Booij, P. Scheltens, P. G. H. M. Raijmakers, A. W. Lemstra
European Journal of Nuclear Medicine and Molecular Imaging.2016; 43(6): 1060. CrossRef
Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies?
Flavio Nobili, Dario Arnaldi, Silvia Morbelli
European Journal of Nuclear Medicine and Molecular Imaging.2016; 43(6): 1056. CrossRef
Imaging Systemic Dysfunction in Parkinson’s Disease
Per Borghammer, Karoline Knudsen, David J. Brooks
Current Neurology and Neuroscience Reports.2016;[Epub] CrossRef
123I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography and 123I‐metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study
Pietro Tiraboschi, Angelo Corso, Ugo Paolo Guerra, Flavio Nobili, Arnoldo Piccardo, Maria Lucia Calcagni, Duccio Volterrani, Diego Cecchin, Mauro Tettamanti, Luigi Antelmi, Simone Vidale, Leonardo Sacco, Maria Merello, Stefano Stefanini, Anna Micheli, Pao
Annals of Neurology.2016; 80(3): 368. CrossRef
On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases
Hayato Odagiri, Toru Baba, Yoshiyuki Nishio, Osamu Iizuka, Minoru Matsuda, Kentaro Inoue, Akio Kikuchi, Takafumi Hasegawa, Masashi Aoki, Atsushi Takeda, Yasuyuki Taki, Etsuro Mori, John Duda
PLOS ONE.2016; 11(4): e0152746. CrossRef
123I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease
Joong-Seok Kim, Hyung-Eun Park, Yoon-Sang Oh, In-Uk Song, Dong-Won Yang, Jeong-Wook Park, Kwang-Soo Lee
Journal of the Neurological Sciences.2015; 357(1-2): 173. CrossRef
Orthostatic hypotension: managing a difficult problem
Pearl K Jones, Brett H Shaw, Satish R Raj
Expert Review of Cardiovascular Therapy.2015; 13(11): 1263. CrossRef

Hereditary Cerebellar Ataxias: A Korean Perspective: Ji Sun Kim, Jin Whan Cho; J Mov Disord. 2015;8(2):67-75. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15006

17,129 View
237 Download
16 Web of Science
15 Crossref

Abstract PDF

Hereditary ataxia is a heterogeneous disorder characterized by progressive ataxia combined with/without peripheral neuropathy, extrapyramidal symptoms, pyramidal symptoms, seizure, and multiple systematic involvements. More than 35 autosomal dominant cerebellar ataxias have been designated as spinocerebellar ataxia, and there are 55 recessive ataxias that have not been named systematically. Conducting genetic sequencing to confirm a diagnosis is difficult due to the large amount of subtypes with phenotypic overlap. The prevalence of hereditary ataxia can vary among countries, and estimations of prevalence and subtype frequencies are necessary for planning a diagnostic strategy in a specific population. This review covers the various hereditary ataxias reported in the Korean population with a focus on the prevalence and subtype frequencies as the clinical characteristics of the various subtypes.

Citations

Citations to this article as recorded by

MRl and MRS hints for the differentiation of cerebellar multiple system atrophy from spinocerebellar ataxia type II
Hung-Chieh Chen, Li-Hua Lee, Jiing-Feng Lirng, Bing-wen Soong
Heliyon.2024; 10(7): e29265. CrossRef
Discovery of a de novo ITPR1 missense mutation in a patient with early‐onset cerebellar ataxia: A rare case report of spinocerebellar ataxia 29
Jae In Lee, Ja Young Choi, Shin‐Seung Yang
Molecular Genetics & Genomic Medicine.2024;[Epub] CrossRef
Placebo response in degenerative cerebellar ataxias: a descriptive review of randomized, placebo-controlled trials
Ji-Hyun Choi, Chaewon Shin, Han-Joon Kim, Beomseok Jeon
Journal of Neurology.2022; 269(1): 62. CrossRef
New Perspectives of Gene Therapy on Polyglutamine Spinocerebellar Ataxias: From Molecular Targets to Novel Nanovectors
Fabiola V. Borbolla-Jiménez, María Luisa Del Prado-Audelo, Bulmaro Cisneros, Isaac H. Caballero-Florán, Gerardo Leyva-Gómez, Jonathan J. Magaña
Pharmaceutics.2021; 13(7): 1018. CrossRef
Serum neurofilament light chain as a severity marker for spinocerebellar ataxia
Hye-Rim Shin, Jangsup Moon, Woo-Jin Lee, Han Sang Lee, Eun Young Kim, Seoyi Shin, Soon-Tae Lee, Keun-Hwa Jung, Kyung-Il Park, Ki-Young Jung, Sang Kun Lee, Kon Chu
Scientific Reports.2021;[Epub] CrossRef
Essential tremor: the most common form of cerebellar degeneration?
Elan D. Louis, Phyllis L. Faust
Cerebellum & Ataxias.2020;[Epub] CrossRef
Identifying SYNE1 ataxia and extending the mutational spectrum in Korea
Ji Sun Kim, Ah Reum Kim, Jinyoung Youn, Chung Lee, Nam-Soon Kim, Woong-Yang Park, Jong Kyu Park, Nayoung K.D. Kim, Jin Whan Cho
Parkinsonism & Related Disorders.2019; 58: 74. CrossRef
Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations
Hiroya Naruse, Takashi Matsukawa, Hiroyuki Ishiura, Jun Mitsui, Yuji Takahashi, Hiroki Takano, Jun Goto, Tatsushi Toda, Shoji Tsuji
neurogenetics.2019; 20(2): 65. CrossRef
Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population
Szu‐Ju Chen, Ni‐Chung Lee, Yin‐Hsiu Chien, Wuh‐Liang Hwu, Chin‐Hsien Lin
Brain and Behavior.2019;[Epub] CrossRef
Differential value of brain magnetic resonance imaging in multiple system atrophy cerebellar phenotype and spinocerebellar ataxias
Minkyeong Kim, Jong Hyeon Ahn, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Jin Whan Cho
Scientific Reports.2019;[Epub] CrossRef
The Etiologies of Chronic Progressive Cerebellar Ataxia in a Korean Population
Ji Sun Kim, Soonwook Kwon, Chang-Seok Ki, Jinyoung Youn, Jin Whan Cho
Journal of Clinical Neurology.2018; 14(3): 374. CrossRef
Cross-cultural adaptation and validation of the International Cooperative Ataxia Rating Scale (ICARS) to Brazilian Portuguese
Fernanda Aparecida Maggi, Pedro Braga-Neto, Hsin Fen Chien, Maria Thereza Drumond Gama, Flávio Moura Rezende Filho, Maria Luiza Saraiva-Pereira, Laura Bannach Jardim, Mariana Callil Voos, José Luiz Pedroso, Orlando Graziani Povoas Barsottini
Arquivos de Neuro-Psiquiatria.2018; 76(10): 674. CrossRef
The c-Abl inhibitor, nilotinib, as a potential therapeutic agent for chronic cerebellar ataxia
Woo-Jin Lee, Jangsup Moon, Tae-Joon Kim, Jin-Sun Jun, Han Sang Lee, Young Jin Ryu, Soon-Tae Lee, Keun-Hwa Jung, Kyung-Il Park, Ki-Young Jung, Manho Kim, Sang Kun Lee, Kon Chu
Journal of Neuroimmunology.2017; 309: 82. CrossRef
Genetic Variants Associated with Episodic Ataxia in Korea
Kwang-Dong Choi, Ji-Soo Kim, Hyo-Jung Kim, Ileok Jung, Seong-Hae Jeong, Seung-Han Lee, Dong Uk Kim, Sang-Ho Kim, Seo Young Choi, Jin-Hong Shin, Dae-Seong Kim, Kyung-Pil Park, Hyang-Sook Kim, Jae-Hwan Choi
Scientific Reports.2017;[Epub] CrossRef
Ataxia with Oculomotor Apraxia Type 1 without Oculomotor Apraxia: A Case Report
Minwoo Lee, Nan Young Kim, Jin Young Huh, Young Eun Kim, Yun Joong Kim
Journal of Clinical Neurology.2016; 12(1): 126. CrossRef

Gastrointestinal Autonomic Dysfunction in Patients with Parkinson’s Disease: Joong-Seok Kim, Hye-Young Sung; J Mov Disord. 2015;8(2):76-82. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15008

42,623 View
282 Download
45 Web of Science
47 Crossref

Abstract PDF

Currently, gastrointestinal dysfunctions in Parkinson’s disease (PD) are well-recognized problems and are known to be an initial symptom in the pathological process that eventually results in PD. Gastrointestinal symptoms may result from the involvement of either the central or enteric nervous systems, or these symptoms may be side effects of antiparkinsonian medications. Weight loss, excessive salivation, dysphagia, nausea/gastroparesis, constipation, and defecation dysfunction all may occur. Increased identification and early detection of these symptoms can result in a significant improvement in the quality of life for PD patients.

Citations

Citations to this article as recorded by

Neurotoxic phospholipase A2: A proposed cause of equine grass sickness and other animal dysautonomias (multiple system neuropathies)
Bruce McGorum, R. Scott Pirie, Luca Bano, Tracey Davey, John Harris, Cesare Montecucco
Equine Veterinary Journal.2025; 57(1): 11. CrossRef
Regulation of Pain Perception by Microbiota in Parkinson Disease
Zulmary Manjarres, Margarita Calvo, Rodrigo Pacheco, Habibeh Khoshbouei
Pharmacological Reviews.2024; 76(1): 7. CrossRef
Emerging wearable technologies for multisystem monitoring and treatment of Parkinson’s disease: a narrative review
Yasmine M. Kehnemouyi, Todd P. Coleman, Peter A. Tass
Frontiers in Network Physiology.2024;[Epub] CrossRef
ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson’s disease mouse models
Fen Zhang, Lixin Pan, Changlin Lian, Zhifeng Xu, Hongda Chen, Wenjie Lai, Xiaojue Liang, Qiyuan Liu, Haomin Wu, Yukai Wang, Pande Zhang, Guohua Zhang, Zhen Liu
Brain Research Bulletin.2024; 214: 110989. CrossRef
Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice
Huijia Yang, Yaping Shao, Yiying Hu, Jin Qian, Panpan Wang, Lulu Tian, Yang Ni, Song Li, Murad Al‐Nusaif, Cong Liu, Weidong Le
CNS Neuroscience & Therapeutics.2024;[Epub] CrossRef
N-acetyl-L-leucine protects MPTP-treated Parkinson’s disease mouse models by suppressing Desulfobacterota via the gut-brain axis
Zhifeng Xu, Changlin Lian, Lixin Pan, Wenjie Lai, Fen Zhang, Lingmei Peng, Sijie Zhou, Guanghua Zhao, Xuezhu Yang, Guohua Zhang, Zefeng Tan, Yukai Wang
Brain Research Bulletin.2023; 202: 110729. CrossRef
Anesthetic Considerations for Cataract Surgery in Patients with Parkinson’s Disease: A Narrative Review
Alyssa Chiew, David Mathew, Chandra M. Kumar, Edwin Seet, Farnad Imani, Seyed-Hossein Khademi
Anesthesiology and Pain Medicine.2023;[Epub] CrossRef
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
Nirav Yogesh Bhatia, Manjiri Prabhakar Jalgaonkar, Anuja Balu Hargude, Atul P. Sherje, Manisha Jignesh Oza, Gaurav Mahesh Doshi
CNS & Neurological Disorders - Drug Targets.2023; 22(7): 1008. CrossRef
A look back at the prodromal findings in Parkinson’s disease
Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
Bulletin of the National Research Centre.2023;[Epub] CrossRef
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration.2023;[Epub] CrossRef
Association between malnutrition and motor/non-motor symptoms in elderly with Parkinson disease
Heewon Bae, Sang-Won Ha
Journal of Geriatric Neurology.2023; 2(2): 58. CrossRef
Gastrointestinal Sensory Neuropathy and Dysmotility in Fabry Disease: Presentations and Effect on Patient's Quality of Life
Nir Bar, Amel Karaa, Katheryn Kiser, Braden Kuo, Claire Zar-Kessler
Clinical and Translational Gastroenterology.2023; 14(12): e00633. CrossRef
Nutritional aspects in Parkinson’s disease
Paulina Gątarek, Joanna Kałużna-Czaplińska
Critical Reviews in Food Science and Nutrition.2022; 62(23): 6467. CrossRef
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo
Nutrients.2022; 14(2): 380. CrossRef
Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait
Li-Li Zhang, Liang Zhang, Jingde Dong, Ying Zhao, Xiao-Ping Wang
Frontiers in Neurology.2022;[Epub] CrossRef
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Tong Guo, Li Chen
European Journal of Inflammation.2022;[Epub] CrossRef
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Sujith Pavan, Arvind N. Prabhu, Sankar Prasad Gorthi, Bhabatosh Das, Ankur Mutreja, Vignesh Shetty, Thandavarayan Ramamurthy, Mamatha Ballal
Folia Microbiologica.2022; 67(5): 693. CrossRef
Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders
Parvin Oroojzadeh, Saber Yari Bostanabad, Hajie Lotfi
Journal of Molecular Neuroscience.2022; 72(9): 1952. CrossRef
Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease
Jinyoung Youn, George Umemoto, Eungseok Oh, Jinse Park, Wooyoung Jang, Yoon-Sang Oh, Hee-Tae Kim, Jin Whan Cho, Shinsuke Fujioka, Yoshio Tsuboi
Frontiers in Neurology.2022;[Epub] CrossRef
The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders
Yasir Bashir, Asad U. Khan
Frontiers in Neuroscience.2022;[Epub] CrossRef
Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun
Microbial Pathogenesis.2021; 150: 104675. CrossRef
Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis
Zhe Zhao, Fangyuan Li, Jingwen Ning, Ran Peng, Junmei Shang, Hui Liu, Meiyu Shang, Xiu-Qi Bao, Dan Zhang
Acta Pharmaceutica Sinica B.2021;[Epub] CrossRef
Murine Esophagus Expresses Glial-Derived Central Nervous System Antigens
Christopher Kapitza, Rittika Chunder, Anja Scheller, Katherine S. Given, Wendy B. Macklin, Michael Enders, Stefanie Kuerten, Winfried L. Neuhuber, Jürgen Wörl
International Journal of Molecular Sciences.2021; 22(6): 3233. CrossRef
Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson’s Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein
Zhe Zhong, Weijie Chen, Huan Gao, Ningning Che, Min Xu, Lanqing Yang, Yingfang Zhang, Min Ye
Neurochemical Research.2021; 46(11): 3050. CrossRef
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
Shanti Diwakarla, Rachel M. McQuade, Remy Constable, Olivia Artaiz, Enie Lei, Kevin J. Barnham, Paul A. Adlard, Robert A. Cherny, Madeleine R. Di Natale, Hongyi Wu, Xin-yi Chai, Victoria A. Lawson, David I. Finkelstein, John B. Furness
Journal of Parkinson's Disease.2021; 11(4): 1821. CrossRef
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź
Pharmacological Research.2021; 172: 105840. CrossRef
Transplantation of gut microbiota derived from Alzheimer’s disease mouse model impairs memory function and neurogenesis in C57BL/6 mice
Namkwon Kim, Seung Ho Jeon, In Gyoung Ju, Min Sung Gee, Jimin Do, Myung Sook Oh, Jong Kil Lee
Brain, Behavior, and Immunity.2021; 98: 357. CrossRef
Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
Sachin Kumar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harassi, Mohammed M. Abdel-Daim, Simona Bungau
Neurotoxicity Research.2021; 39(6): 2141. CrossRef
Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
Zhe Zhao, Jingwen Ning, Xiu-qi Bao, Meiyu Shang, Jingwei Ma, Gen Li, Dan Zhang
Microbiome.2021;[Epub] CrossRef
Chronic isolation stress is associated with increased colonic and motor symptoms in the A53T mouse model of Parkinson’s disease
Shanti Diwakarla, David I. Finkelstein, Remy Constable, Olivia Artaiz, Madeleine Di Natale, Rachel M. McQuade, Enie Lei, Xin‐yi Chai, Mitchell T. Ringuet, Linda J. Fothergill, Victoria A. Lawson, Laura J. Ellett, Joel P. Berger, John B. Furness
Neurogastroenterology & Motility.2020;[Epub] CrossRef
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Pa
European Journal of Pharmaceutical Sciences.2020; 147: 105280. CrossRef
Estado nutricional de idosos com doença de Parkinson e seus fatores associados: uma revisão integrativa
Nívola Beatriz Mendonça de Arruda, Suelane Renata de Andrade Silva, Nadja Maria Jorge Asano, Maria das Graças Wanderley de Sales Coriolano
Revista Brasileira de Geriatria e Gerontologia.2020;[Epub] CrossRef
Probiotics for Parkinson’s Disease
Parisa Gazerani
International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease
Eliseu da Cruz Moreira-Junior
Medical Hypotheses.2019; 133: 109399. CrossRef
Constipation Increases Disability and Decreases Dopamine Levels in the Nigrostriatal System through Gastric Inflammatory Factors in Parkinson’s Disease
Yongtao Zhou, Yusheng Su, Weihua Xu, Wei Wang, Shukun Yao
Current Neurovascular Research.2019; 16(3): 241. CrossRef
α-Synuclein Regulates Development and Function of Cholinergic Enteric Neurons in the Mouse Colon
M. Swaminathan, C. Fung, D.I. Finkelstein, J.C. Bornstein, J.P.P. Foong
Neuroscience.2019; 423: 76. CrossRef
Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway
Meng-Fei Sun, Ying-Li Zhu, Zhi-Lan Zhou, Xue-Bing Jia, Yi-Da Xu, Qin Yang, Chun Cui, Yan-Qin Shen
Brain, Behavior, and Immunity.2018; 70: 48. CrossRef
Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease
Meng-Fei Sun, Yan-Qin Shen
Ageing Research Reviews.2018; 45: 53. CrossRef
Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK
Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden
British Journal of Clinical Pharmacology.2018; 84(11): 2551. CrossRef
Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial
Tsuyoshi Miyaoka, Misako Kanayama, Rei Wake, Sadayuki Hashioka, Maiko Hayashida, Michiharu Nagahama, Shihoh Okazaki, Satoko Yamashita, Shoko Miura, Hiroyuki Miki, Hiroyuki Matsuda, Masahiro Koike, Muneto Izuhara, Tomoko Araki, Keiko Tsuchie, Ilhamuddin Ab
Clinical Neuropharmacology.2018; 41(5): 151. CrossRef
Role of Microbiota in Neurodegenerative Diseases
C. V. Sobol
Russian Journal of Developmental Biology.2018; 49(6): 297. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
Neurological Sciences.2017; 38(1): 171. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective
Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little, Han Joon Kim
Expert Review of Neurotherapeutics.2017; 17(7): 737. CrossRef
Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota
Jing Sun, Fangyan Wang, Zongxin Ling, Xichong Yu, Wenqian Chen, Haixiao Li, Jiangtao Jin, Mengqi Pang, Huiqing Zhang, Junjie Yu, Jiaming Liu
Brain Research.2016; 1642: 180. CrossRef
Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study
Chava Peretz, Ron Gurel, Violet Rozani, Tanya Gurevich, Baruch El-Ad, Judith Tsamir, Nir Giladi
Parkinsonism & Related Disorders.2016;[Epub] CrossRef
An Incidental Finding of a Radiopaque Pill following Cervical Spinal Surgery in a Parkinson's Disease Patient
Bon Sub Gu, Soo-Jung Choi, Byoungwoo Yoo, Koon Hee Han, Jong Kyu Park, Young-Seok Lee, Jin Hoon Park
Korean Journal of Spine.2015; 12(3): 153. CrossRef

Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease: Han-Joon Kim, Beom S. Jeon, Sun Ha Paek; J Mov Disord. 2015;8(2):83-91. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15010

25,669 View
252 Download
59 Web of Science
51 Crossref

Abstract PDF

Subthalamic deep brain stimulation (STN DBS) is an established treatment for the motor symptoms in patients with advanced Parkinson’s disease (PD). In addition to improvements in motor symptoms, many studies have reported changes in various nonmotor symptoms (NMSs) after STN DBS in patients with PD. Psychiatric symptoms, including depression, apathy, anxiety, and impulsivity, can worsen or improve depending on the electrical stimulation parameters, the locations of the stimulating contacts within the STN, and changes in medications after surgery. Global cognitive function is not affected by STN DBS, and there is no increase in the incidence of dementia after STN DBS compared to that after medical treatment, although clinically insignificant declines in verbal fluency have been consistently reported. Pain, especially PD-related pain, improves with STN DBS. Evidence regarding the effects of STN DBS on autonomic symptoms and sleep-related problems is limited and remains conflicting. Many symptoms of nonmotor fluctuations, which are occasionally more troublesome than motor fluctuations, improve with STN DBS. Although it is clear that NMSs are not target symptoms for STN DBS, NMSs have a strong influence on the quality of life of patients with PD, and clinicians should thus be aware of these NMSs when deciding whether to perform surgery and should pay attention to changes in these symptoms after STN DBS to ensure the optimal care for patients.

Citations

Citations to this article as recorded by

Preoperative Attention/Memory Problem Affects the Quality of Life of Parkinson’s Disease Patients after Deep Brain Stimulation: A Cohort Study
Ying Gao, Jue Wang, Linbin Wang, Dianyou Li, Bomin Sun, Xian Qiu, Shiek Ahmed
Parkinson's Disease.2024; 2024: 1. CrossRef
Neurocognitive changes at different follow-up times after bilateral subthalamic nucleus deep brain stimulation in patients with Parkinson's disease
Zhuohang Wang, Zijian Zheng, Junwen Huang, Xu Cai, Xinjie Liu, Cheng Xue, Longping Yao, Guohui Lu
Heliyon.2024; 10(4): e26303. CrossRef
Investigation of the nonmotor symptoms in patients with STN-DBS therapy in comparison with those without STN-DBS
Halil Onder, Selcuk Comoglu
Journal of Neural Transmission.2024; 131(8): 931. CrossRef
The Protective Role of Cognitive Reserve: A Preliminary Study on Parkinsonian Patients Undergoing Deep Brain Stimulation
Eleonora Zirone, Fabiana Ruggiero, Maria Takeko Molisso, Roberta Ferrucci, Angelica De Sandi, Angelica Marfoli, Denise Mellace, Filippo Cogiamanian, Linda Borellini, Enrico Mailland, Elena Pirola, Antonella Ampollini, Marco Locatelli, Sergio Barbieri, Fra
Journal of Clinical Medicine.2024; 13(15): 4578. CrossRef
Circuit-Specific Deep Brain Stimulation Provides Insights into Movement Control
Aryn H. Gittis, Roy V. Sillitoe
Annual Review of Neuroscience .2024; 47(1): 63. CrossRef
An escape-enhancing circuit involving subthalamic CRH neurons mediates stress-induced anhedonia in mice
Binghao Zhao, Lisha Liang, Jingfei Li, Bernhard Schaefke, Liping Wang, Yu-Ting Tseng
Neurobiology of Disease.2024; 200: 106649. CrossRef
Effect of deep brain stimulation on sexual dysfunction among patients who had Parkinson’s disease: a systematic review and meta-analysis
Amir Reza Bahadori, Rasa Zafari, Mohammad Amin Fathollahi, Afshan Davari, Mehrdad Sheikhvatan, Sara Ranji, Abbas Tafakhori
Neurological Research.2024; 46(12): 1181. CrossRef
A Wellness Prescription for Parkinson's: Mid to Late-stage Disease
Gregory M Pontone, Bradley McDaniels, Adrienne M Keener, Indu Subramanian
The American Journal of Geriatric Psychiatry.2023;[Epub] CrossRef
Impact of deep brain stimulation (DBS) on olfaction in Parkinson's disease: Clinical features and functional hypotheses
G. Brand, C. Bontempi, L. Jacquot
Revue Neurologique.2023; 179(9): 947. CrossRef
Time-locked acute alpha-frequency stimulation of subthalamic nuclei during the evaluation of emotional stimuli and its effect on power modulation
Naeem Muhammad, Saurabh Sonkusare, Qiong Ding, Linbin Wang, Alekhya Mandali, Yi Jie Zhao, Bomin Sun, Dianyou Li, Valerie Voon
Frontiers in Human Neuroscience.2023;[Epub] CrossRef
Nutraceuticals a Food for Thought in the Treatment of Parkinson’s Disease
Keshav Bansal, Sakshi Singh, Vanshita Singh, Meenakshi Bajpai
Current Nutrition & Food Science.2023; 19(9): 961. CrossRef
Subthalamic Nucleus Stimulation in Parkinson's Disease: 5‐Year Extension Study of a Randomized Trial
Silje Bjerknes, Mathias Toft, Reidun Brandt, Trine Waage Rygvold, Ane Konglund, Espen Dietrichs, Stein Andersson, Inger Marie Skogseid
Movement Disorders Clinical Practice.2022; 9(1): 48. CrossRef
Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis
Zahra Eghlidos, Zahra Rahimian, Gholamreza Vadiee, Soodeh Jahangiri
Acta Neurologica Scandinavica.2022; 146(2): 115. CrossRef
Nomogram for Predicting Depression Improvement after Deep Brain Stimulation for Parkinson’s Disease
Bowen Chang, Chen Ni, Jiaming Mei, Chi Xiong, Peng Chen, Manli Jiang, Chaoshi Niu
Brain Sciences.2022; 12(7): 841. CrossRef
A nigra–subthalamic circuit is involved in acute and chronic pain states
Cui Yin, Tao Jia, Yiwen Luan, Xue Zhang, Cheng Xiao, Chunyi Zhou
Pain.2022; 163(10): 1952. CrossRef
A nigro–subthalamo–parabrachial pathway modulates pain-like behaviors
Tao Jia, Ying-Di Wang, Jing Chen, Xue Zhang, Jun-Li Cao, Cheng Xiao, Chunyi Zhou
Nature Communications.2022;[Epub] CrossRef
Basal impulses: findings from the last twenty years on impulsivity and reward pathways using deep brain stimulation
Pavan S. UPADHYAYULA, Robert C. RENNERT, Joel R. MARTIN, John K. YUE, Jason YANG, Eva M. GILLIS-BUCK, Nikki SIDHU, Christopher K. CHEUNG, Anthony T. LEE, Reid R. HOSHIDE, Joseph D. CIACCI
Journal of Neurosurgical Sciences.2021;[Epub] CrossRef
Pallidal versus subthalamic deep-brain stimulation for meige syndrome: a retrospective study
Jiayu Liu, Hu Ding, Ke Xu, Ruen Liu, Dongliang Wang, Jia Ouyang, Zhi Liu, Zeyu Miao
Scientific Reports.2021;[Epub] CrossRef
Eight‐year follow‐up outcome of subthalamic deep brain stimulation for Parkinson’s disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity
Lulu Jiang, Wanru Chen, Qiyu Guo, Chao Yang, Jing Gu, Wenbiao Xian, Yanmei Liu, Yifan Zheng, Jing Ye, Shaohua Xu, Yu Hu, Lei Wu, Jie Chen, Hao Qian, Xiaoli Fu, Jinlong Liu, Ling Chen
CNS Neuroscience & Therapeutics.2021; 27(11): 1366. CrossRef
Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease
Gabriele Bellini, Laura A. Best, Una Brechany, Russell Mills, Nicola Pavese
Movement Disorders Clinical Practice.2020; 7(4): 373. CrossRef
Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice
Yiwen Luan, Dongliang Tang, Haichuan Wu, Weixin Gu, Yuqing Wu, Jun-Li Cao, Cheng Xiao, Chunyi Zhou
Proceedings of the National Academy of Sciences.2020; 117(18): 10045. CrossRef
Impulsivity and Compulsivity After Subthalamic Deep Brain Stimulation for Parkinson’s Disease
Sara Scherrer, Andrew H. Smith, Jaimie Gowatsky, Christina A. Palmese, Joohi Jimenez-Shahed, Brian H. Kopell, Helen S. Mayberg, Martijn Figee
Frontiers in Behavioral Neuroscience.2020;[Epub] CrossRef
Deep brain stimulation and recordings: Insights into the contributions of subthalamic nucleus in cognition
Neil M. Drummond, Robert Chen
NeuroImage.2020; 222: 117300. CrossRef
Bilateral Subthalamic Nucleus Deep Brain Stimulation under General Anesthesia: Literature Review and Single Center Experience
Hye Ran Park, Yong Hoon Lim, Eun Jin Song, Jae Meen Lee, Kawngwoo Park, Kwang Hyon Park, Woong-Woo Lee, Han-Joon Kim, Beomseok Jeon, Sun Ha Paek
Journal of Clinical Medicine.2020; 9(9): 3044. CrossRef
Subthalamic deep brain stimulation improves sleep and excessive sweating in Parkinson’s disease
Silje Bjerknes, Inger Marie Skogseid, Tuva Jin Hauge, Espen Dietrichs, Mathias Toft
npj Parkinson's Disease.2020;[Epub] CrossRef
Impacto de la estimulación subtalámica a largo plazo sobre la situación cognitiva de los pacientes con enfermedad de Parkinson avanzada
M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban
Neurología.2019; 34(9): 573. CrossRef
The Subthalamic Nucleus: Unravelling New Roles and Mechanisms in the Control of Action
Tora Bonnevie, Kareem A. Zaghloul
The Neuroscientist.2019; 25(1): 48. CrossRef
Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease
U. Hidding, A. Gulberti, C. Pflug, C. Choe, A. Horn, L. Prilop, H. Braaß, O. Fründt, C. Buhmann, D. Weiss, M. Westphal, A.K. Engel, C. Gerloff, J.A. Köppen, W. Hamel, C.K.E. Moll, M. Pötter-Nerger
Parkinsonism & Related Disorders.2019; 62: 141. CrossRef
Zona incerta GABAergic neurons integrate prey-related sensory signals and induce an appetitive drive to promote hunting
Zheng-dong Zhao, Zongming Chen, Xinkuan Xiang, Mengna Hu, Hengchang Xie, Xiaoning Jia, Fang Cai, Yuting Cui, Zijun Chen, Lechen Qian, Jiashu Liu, Congping Shang, Yiqing Yang, Xinyan Ni, Wenzhi Sun, Ji Hu, Peng Cao, Haohong Li, Wei L. Shen
Nature Neuroscience.2019; 22(6): 921. CrossRef
Long-term impact of subthalamic stimulation on cognitive function in patients with advanced Parkinson's disease
M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban
Neurología (English Edition).2019; 34(9): 573. CrossRef
Influencia de la estimulación cerebral profunda en la carga de cuidadores de pacientes con enfermedad de Parkinson
J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos
Neurología.2018; 33(3): 154. CrossRef
Alteration in the Local and Global Functional Connectivity of Resting State Networks in Parkinson’s Disease
Maryam Ghahremani, Jaejun Yoo, Sun Ju Chung, Kwangsun Yoo, Jong C. Ye, Yong Jeong
Journal of Movement Disorders.2018; 11(1): 13. CrossRef
Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden
J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos
Neurología (English Edition).2018; 33(3): 154. CrossRef
Clinical Markers of Anxiety Subtypes in Parkinson Disease
Martinus P. G. Broen, A. F. G. Leentjens, J. T. Hinkle, A. J. H. Moonen, M. L. Kuijf, N. M. Fischer, K. Perepezko, A. Bakker, G. M. Pontone
Journal of Geriatric Psychiatry and Neurology.2018; 31(2): 55. CrossRef
Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease: A Meta-Analysis
Ying Wang, Yongsheng Li, Xiaona Zhang, Anmu Xie
Parkinson's Disease.2018; 2018: 1. CrossRef
Non-motor Characterization of the Basal Ganglia: Evidence From Human and Non-human Primate Electrophysiology
Robert S. Eisinger, Morgan E. Urdaneta, Kelly D. Foote, Michael S. Okun, Aysegul Gunduz
Frontiers in Neuroscience.2018;[Epub] CrossRef
Revealing a novel nociceptive network that links the subthalamic nucleus to pain processing
Arnaud Pautrat, Marta Rolland, Margaux Barthelemy, Christelle Baunez, Valérie Sinniger, Brigitte Piallat, Marc Savasta, Paul G Overton, Olivier David, Veronique Coizet
eLife.2018;[Epub] CrossRef
Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery—A retrospective analysis of patients that underwent surgery between 1993 and 2001
Radu Constantinescu, Kaj Blennow, Lars Rosengren, Barbro Eriksson, Thordis Gudmundsdottir, Yvonne Jansson, Bo Johnels, Annika Renck, Filip Bergquist
Clinical Neurology and Neurosurgery.2018; 174: 174. CrossRef
Predictors to quality of life improvements after subthalamic stimulation in Parkinson’s disease
Feng‐Tao Liu, Li‐Qin Lang, Yu‐Jie Yang, Jue Zhao, Rui Feng, Jie Hu, Jian Wang, Jian‐Jun Wu
Acta Neurologica Scandinavica.2018;[Epub] CrossRef
Apathy associated with neurocognitive disorders: Recent progress and future directions
Krista L. Lanctôt, Luis Agüera‐Ortiz, Henry Brodaty, Paul T. Francis, Yonas E. Geda, Zahinoor Ismail, Gad A. Marshall, Moyra E. Mortby, Chiadi U. Onyike, Prasad R. Padala, Antonios M. Politis, Paul B. Rosenberg, Emma Siegel, David L. Sultzer, Eleenor H. A
Alzheimer's & Dementia.2017; 13(1): 84. CrossRef
Can deep brain stimulation be a therapeutic option for Parkinson's disease dementia?
Han‐Joon Kim, Beomseok Jeon, Jee‐Young Lee, Sun Ha Paek
Neurology and Clinical Neuroscience.2017; 5(1): 3. CrossRef
The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence
Mónica M Kurtis, Thadshani Rajah, Luisa F Delgado, Haidar S Dafsari
npj Parkinson's Disease.2017;[Epub] CrossRef
Delayed responses of subthalamic nucleus to deep brain stimulation in patients with Parkinson's disease
Lin Shi, Kai Zhang, Fan-Gang Meng, Guan-Yu Zhu, Ying-Chuan Chen, Jun-Jian Zhou, Zhong-Hai Zhou, Jian-Guo Zhang
Parkinsonism & Related Disorders.2017; 40: 76. CrossRef
Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease
Margherita Fabbri, Miguel Coelho, Leonor Correia Guedes, Mario M. Rosa, Daisy Abreu, Nilza Gonçalves, Angelo Antonini, Joaquim J. Ferreira
Parkinsonism & Related Disorders.2017;[Epub] CrossRef
Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals
Kathrin Badstuebner, Ulrike Gimsa, Immo Weber, Armin Tuchscherer, Jan Gimsa
Parkinson's Disease.2017; 2017: 1. CrossRef
Current Topics in Deep Brain Stimulation for Parkinson Disease
Atsushi UMEMURA, Genko OYAMA, Yasushi SHIMO, Madoka NAKAJIMA, Asuka NAKAJIMA, Takayuki JO, Satoko SEKIMOTO, Masanobu ITO, Takumi MITSUHASHI, Nobutaka HATTORI, Hajime ARAI
Neurologia medico-chirurgica.2016; 56(10): 613. CrossRef
In Parkinson’s disease STN stimulation enhances responsiveness of movement initiation speed to high reward value
Maja Kojovic, Andrea Higgins, Marjan Jahanshahi
Neuropsychologia.2016; 89: 273. CrossRef
Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson’s Disease
Lei-Fang Cao, Xiao-Yan Peng, Ya Huang, Bing Wang, Feng-Ming Zhou, Ruo-Xiao Cheng, Li-Hua Chen, Wei-Feng Luo, Tong Liu
Neural Plasticity.2016; 2016: 1. CrossRef
The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
Do-Young Kwon, Seong-Beom Koh, Jae Hyeok Lee, Hee Kyung Park, Han-Joon Kim, Hae-Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim, Seong-Min Choi, Ji-Yun Park, Beom S. Jeon, Ji Young Kim, Sun Ju Chung, Chong Sik Lee, Jeong-Ho Park, Tae-Beom
Journal of Clinical Neurology.2016; 12(4): 393. CrossRef
Antiparkinsonian Treatment for Depression in Parkinson's Disease: Are Selective Serotonin Reuptake Inhibitors Recommended?
Philippe De Deurwaerdère, Yuqiang Ding
Translational Neuroscience and Clinics.2016; 2(2): 138. CrossRef
The Subthalamic Nucleus, Limbic Function, and Impulse Control
P. Justin Rossi, Aysegul Gunduz, Michael S. Okun
Neuropsychology Review.2015; 25(4): 398. CrossRef

Many Faces of Parkinson’s Disease: Non-Motor Symptoms of Parkinson’s Disease: Hye Mi Lee, Seong-Beom Koh; J Mov Disord. 2015;8(2):92-97. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15003

23,810 View
568 Download
111 Web of Science
111 Crossref

Abstract PDF

Parkinson’s disease (PD) is a multi-systemic disorder that is characterized by a combination of motor and non-motor symptoms (NMS). The dopaminergic neurodegeneration of PD is involved in the genesis of NMS, but other conditions and side effects of levodopa are also associated with NMS. NMS can develop at all stage of PD and rapid eyeball movement sleep behavior disorder (RBD), constipation, depression, and olfactory dysfunction are considered prodromal signs of PD. Many NMS related with motor deficits and cognitive dysfunction. Some NMS including olfactory dysfunction, RBD and abnormal stereopsis are associated with presence of other NMS of PD. In addition, several NMS can be helpful to differentiate between idiopathic PD and other parkinsonian disorders. Early recognition and management of NMS in PD patients is important for preserving quality of life.

Citations

Citations to this article as recorded by

Challenges in Managing Nonmotor Symptoms of Parkinson's Disease in Low‐Resourced Settings with Unavailability of Newer Drugs
Zakiyah Aldaajani, Hanan Khalil
Movement Disorders Clinical Practice.2024; 11(2): 123. CrossRef
Is there any correlation between alpha-synuclein levels in tears and retinal layer thickness in Parkinson's disease?
Azyadeh Camacho-Ordonez, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Ana Jimena Hernandez-Medrano, Selma Alin Somilleda-Ventura, Hector J. Pérez-Cano, Ángel Nava-Castañeda, Oscar Guerrero-Berger
European Journal of Ophthalmology.2024; 34(1): 252. CrossRef
Robotic technology for Parkinson's disease: Needs, attitudes and concerns of individuals with Parkinson's disease and their family members. A focus group study
Azriel Kaplan, Shirel Barkan-Slater, Yair Zlotnik, Shelly Levy-Tzedek
International Journal of Human-Computer Studies.2024; 181: 103148. CrossRef
Associations of dual-task walking costs with cognition in Parkinson’s disease
Danial Kazemi, Amir Shayan Chadeganipour, Mina Dehghani, Fatemeh Ghorbali
Gait & Posture.2024; 110: 48. CrossRef
Lifestyle Modulators of Neuroplasticity in Parkinson’s Disease: Evidence in Human Neuroimaging Studies
Silvia Paola Caminiti, Silvia Gallo, Federico Menegon, Andrea Naldi, Cristoforo Comi, Giacomo Tondo
CNS & Neurological Disorders - Drug Targets.2024; 23(5): 602. CrossRef
Buty and the beast: the complex role of butyrate in Parkinson’s disease
Joshua D. Elford, Nanette Becht, Johan Garssen, Aletta D. Kraneveld, Paula Perez-Pardo
Frontiers in Pharmacology.2024;[Epub] CrossRef
Butyrate as a potential therapeutic agent for neurodegenerative disorders
Prapti Chakraborty, Hasinika K.A.H. Gamage, Angela S. Laird
Neurochemistry International.2024; 176: 105745. CrossRef
Real-world Chinese herbal medicine for Parkinson's disease: a hospital-based retrospective analysis of electronic medical records
Shaohua Lyu, Claire Shuiqing Zhang, Zhenhui Mao, Xinfeng Guo, Zhe Li, Xiaodong Luo, Jingbo Sun, Qiaozhen Su
Frontiers in Aging Neuroscience.2024;[Epub] CrossRef
General Treatments Promoting Independent Living in Parkinson’s Patients and Physical Therapy Approaches for Improving Gait—A Comprehensive Review
Dae-Hwan Lee, Bong-Sik Woo, Yong-Hwa Park, Jung-Ho Lee
Medicina.2024; 60(5): 711. CrossRef
Cysteamine HCl Administration Impedes Motor and Olfactory Functions, Accompanied by a Reduced Number of Dopaminergic Neurons, in Experimental Mice: A Preclinical Mimetic Relevant to Parkinson’s Disease
Divya Bharathi Selvaraj, Anusiya Panneerselvam, Jemi Feiona Vergil Andrews, Mahesh Kandasamy
Brain Sciences.2024; 14(7): 632. CrossRef
Revolutionizing our understanding of Parkinson’s disease: Dr. Heinz Reichmann’s pioneering research and future research direction
Masaru Tanaka, László Vécsei
Journal of Neural Transmission.2024; 131(12): 1367. CrossRef
The Impact of the Dietary Intake of Vitamin B12, Folic Acid, and Vitamin D3 on Homocysteine Levels and the Health-Related Quality of Life of Levodopa-Treated Patients with Parkinson’s Disease—A Pilot Study in Romania
Adina Turcu-Stiolica, Mihaela-Simona Naidin, Steliana Halmagean, Ana Ionescu, Ionica Pirici
Diagnostics.2024; 14(15): 1609. CrossRef
Prevalence and clinical correlates of nonmotor symptoms in Parkinson’s disease in a tertiary health-care center in Turkey
H. Onder, S. Comoglu
Neurological Research.2024; 46(11): 1054. CrossRef
Effects of Mucuna pruriens (L.) DC. and Levodopa in Improving Parkinson’s Disease in Rotenone Intoxicated Mice
Sheher Bano Zaigham, Dong-Guk Paeng
Current Issues in Molecular Biology.2024; 46(8): 9234. CrossRef
Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson’s disease
Nayron Medeiros Soares, Pedro Henrique Rodrigues da Silva, Gabriela Magalhães Pereira, Renata Ferranti Leoni, Carlos Roberto de Mello Rieder, Thatiane Alves Pianoschi Alva
Neuroradiology.2024; 66(11): 1955. CrossRef
Commentary on A Meta-Analysis of Exercise Intervention and the Effect on Parkinson’s Disease Symptoms: What Activities Are Best?
Syed Omar Ahmad, Dana Stiles, Emily Born, Julie Scheffler, Katie Vogel
Applied Sciences.2024; 14(16): 7236. CrossRef
Static and Dynamic Functional Network Connectivity in Parkinson's Disease Patients With Postural Instability and Gait Disorder
Bo Shen, Qun Yao, Yixuan Zhang, Yinyin Jiang, Yaxi Wang, Xu Jiang, Yang Zhao, Haiying Zhang, Shuangshuang Dong, Dongfeng Li, Yaning Chen, Yang Pan, Jun Yan, Feng Han, Shengrong Li, Qi Zhu, Daoqiang Zhang, Li Zhang, Yun‐cheng Wu
CNS Neuroscience & Therapeutics.2024;[Epub] CrossRef
Functional neural substrates of Parkinson’s disease and potential underpinnings of acute responses to acupuncture stimulation
Hyoung-Min Lee, Dong-Hyuk Lee, Han-Gyul Lee, Seungwon Kwon, Seung-Yeon Cho, Woo-Sang Jung, Sang-Kwan Moon, Jung-Mi Park, Chang-Nam Ko, Seong-Uk Park
Neuroscience.2024; 562: 148. CrossRef
Clinical characteristics and treatment of psychosis in Parkinson’s disease: A narrative review
Jelena Stamenović, Biljana Živadinović, Vanja Đurić
Journal of the Chinese Medical Association.2024; 87(11): 972. CrossRef
Genetic-based diagnostics of Parkinson’s disease and other Parkinsonian syndromes
Emma N. Somerville, Ziv Gan-Or
Expert Review of Molecular Diagnostics.2024; : 1. CrossRef
Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease
Sadegh Moradi Vastegani, Seyed Esmaeil Khoshnam, Esrafil Mansouri, Somayeh Hajipour, Samireh Ghafouri, Nima Bakhtiari, Alireza Sarkaki, Yaghoob Farbood
Behavioural Brain Research.2023; 437: 114100. CrossRef
The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson’s disease: A double-blind, placebo-controlled, randomized controlled trial
Sanaz Mehrabani, Fariborz Khorvash, Zahra Heidari, Maryam Tajabadi-Ebrahimi, Reza Amani
Journal of Functional Foods.2023; 100: 105397. CrossRef
Role of Ceramides and Sphingolipids in Parkinson's Disease
Melissa Vos, Christine Klein, Andrew A Hicks
Journal of Molecular Biology.2023; 435(12): 168000. CrossRef
Efficacy of herbal medicine treatment based on syndrome differentiation for Parkinson’s disease: A systematic review and meta-analysis of randomized placebo-controlled clinical trials
Purumea Jun, HuiYan Zhao, In Chul Jung, Ojin Kwon, Chang-Hyun Han, Jiyoon Won, Jung-Hee Jang
Frontiers in Pharmacology.2023;[Epub] CrossRef
A meta-analysis of exercise intervention and the effect on Parkinson’s Disease symptoms
Syed Omar Ahmad, Jason Longhurst, Dana Stiles, Lana Downard, Stephanie Martin
Neuroscience Letters.2023; 801: 137162. CrossRef
Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration
Jannis Kountouras, Michael Doulberis, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Zavos, Evangelos Kazakos, Stergios Arapoglou, Foteini Kyrailidi, Maria C. Mouratidou, Marina Boziki, Elisabeth Vardaka
Medicina.2023; 59(3): 504. CrossRef
Case management interventions in chronic disease reduce anxiety and depressive symptoms: A systematic review and meta-analysis
Angelika D. Geerlings, Jules M. Janssen Daalen, Jan H. L. Ypinga, Bastiaan R. Bloem, Marjan J. Meinders, Marten Munneke, Sirwan K. L. Darweesh, Vincenzo De Luca
PLOS ONE.2023; 18(4): e0282590. CrossRef
Bio-synthesized selenium nanoparticles ameliorate Brain oxidative stress in Parkinson disease rat models
Sanaz Salaramoli, Hamed Amiri, Hamid Reza Joshaghani, Mahmoud Hosseini, Seyed Isaac Hashemy
Metabolic Brain Disease.2023; 38(6): 2055. CrossRef
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
Poornima D.E. Weerasinghe-Mudiyanselage, Sohi Kang, Joong-Sun Kim, Changjong Moon
Current Neuropharmacology.2023; 21(3): 560. CrossRef
Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
Dutta Rajib
Journal of Neuroscience and Neurological Disorders.2023; 7(2): 027. CrossRef
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Viviana A. Ruiz-Pozo, Rafael Tamayo-Trujillo, Santiago Cadena-Ullauri, Evelyn Frias-Toral, Patricia Guevara-Ramírez, Elius Paz-Cruz, Sebastián Chapela, Martha Montalván, Tania Morales-López, Daniel Simancas-Racines, Ana Karina Zambrano
Nutrients.2023; 15(16): 3585. CrossRef
Enhancing Parkinson's disease severity assessment through voice-based wavelet scattering, optimized model selection, and weighted majority voting
Farhad Abedinzadeh Torghabeh, Seyyed Abed Hosseini, Elham Ahmadi Moghadam
Medicine in Novel Technology and Devices.2023; 20: 100266. CrossRef
A look back at the prodromal findings in Parkinson’s disease
Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
Bulletin of the National Research Centre.2023;[Epub] CrossRef
Parkinson’s Disease Non-Motor Subtypes Classification in a Group of Slovenian Patients: Actuarial vs. Data-Driven Approach
Timotej Petrijan, Jan Zmazek, Marija Menih
Journal of Clinical Medicine.2023; 12(23): 7434. CrossRef
Unveiling the Hidden Challenges: Non-Motor Disorders in Parkinson’s Disease
Francisco Nieto-Escamez, Esteban Obrero-Gaitán, Héctor García-López, Irene Cortés-Pérez
Brain Sciences.2023; 13(12): 1710. CrossRef
REM sleep behavioral disorder may be an independent risk factor for orthostatic hypotension in Parkinson’s disease
Kangfu Yin, Chuanbin Zhou, Yongyun Zhu, Weifang Yin, Lei Yin, Bin Liu, Hui Ren, Zhong Xu, Xinglong Yang
Aging Clinical and Experimental Research.2022; 34(1): 159. CrossRef
Gender Differences and Impact of Autonomic Disturbance on Fatigue and Quality of Life in Parkinson's Disease
Nahush R Bansal, Birinder S Paul, Gunchan Paul, Gagandeep Singh
Neurology India.2022; 70(1): 203. CrossRef
Exploring Unmet Information Needs of People with Parkinson’s Disease and Their Families: Focusing on Information Sharing in an Online Patient Community
Hyeon Sik Chu, Hye Young Jang
International Journal of Environmental Research and Public Health.2022; 19(5): 2521. CrossRef
Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
Tong Guo, Li Chen
European Journal of Inflammation.2022;[Epub] CrossRef
Diffusion Tensor Imaging Reveals Deep Brain Structure Changes in Early Parkinson’s Disease Patients with Various Sleep Disorders
Yanyan Jiang, Hedi An, Qian Xi, Weiting Yang, Hongrong Xie, Yang Li, Dongya Huang
Brain Sciences.2022; 12(4): 463. CrossRef
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
Hae-Won Shin, Sang-Wook Hong, Young Chul Youn
Journal of Clinical Neurology.2022; 18(3): 259. CrossRef
Effect of mobile health intervention for self-management on self-efficacy, motor and non-motor symptoms, self-management, and quality of life in people with Parkinson's disease: Randomized controlled trial
Yusun Park, Sung Reul Kim, Hui Young So, Sungyang Jo, Seung Hyun Lee, Yun su Hwang, Mi Sun Kim, Sun Ju Chung
Geriatric Nursing.2022; 46: 90. CrossRef
Ghrelin mediated regulation of neurosynaptic transmitters in depressive disorders
Milind V. Masule, Sumit Rathod, Yogeeta Agrawal, Chandragouda R. Patil, Kartik T. Nakhate, Shreesh Ojha, Sameer N. Goyal, Umesh B. Mahajan
Current Research in Pharmacology and Drug Discovery.2022; 3: 100113. CrossRef
Psychosis in Parkinson’s Disease: A Lesson from Genetics
Efthalia Angelopoulou, Anastasia Bougea, Sokratis G. Papageorgiou, Chiara Villa
Genes.2022; 13(6): 1099. CrossRef
Non-motor manifestation of Parkinson's disease: a cross-sectional study in a teaching hospital in Jordan
Said Salah Dahbour, Mohammad J. Al Murr, Liyan H. Oweis, Nada T. Al Antary, Maram Mohsen, Safa Al Fegi
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2022;[Epub] CrossRef
Spectrum of Cardiovascular Autonomic Dysfunction and 24-hour Blood Pressure Variability in Idiopathic Parkinson's Disease
Ivy Sebastian, Mahesh P. Kate, Himani Khatter, Bharat Singh, Jeyaraj D. Pandian
Annals of Indian Academy of Neurology.2022; 25(5): 902. CrossRef
Relationship between Apathy and Subjective Poor Night-time Sleep in de novo, Untreated Parkinson’s Disease
Chae-Moon Hong, Do-Hoon Kim, Byeong-Cheol Ahn, Jong-Geun Seo, Ho-Sung Ryu
Journal of Integrative Neuroscience.2022;[Epub] CrossRef
Neuroprotective effects of probiotics bacteria on animal model of Parkinson’s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study
Esmail Alipour Nosrani, Omid Reza Tamtaji, Zahra Alibolandi, Parichehr Sarkar, Mohsen Ghazanfari, Abolfazl Azami Tameh, Mohsen Taghizadeh, Zarrin Banikazemi, Razie Hadavi, Mojtaba Naderi Taheri
Journal of Immunoassay and Immunochemistry.2021; 42(2): 106. CrossRef
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
Ana Gómez-López, Arantxa Sánchez-Sánchez, Elena Natera-Villalba, Victoria Ros-Castelló, Álvaro Beltrán-Corbellini, Samira Fanjul-Arbós, Isabel Pareés Moreno, José Luis López-Sendon Moreno, Juan Carlos Martínez Castrillo, Araceli Alonso-Canovas
Brain Sciences.2021; 11(1): 57. CrossRef
People with Parkinson’s Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration?
Rebecca J. Port, Martin Rumsby, Graham Brown, Ian F. Harrison, Anneesa Amjad, Claire J. Bale
Journal of Parkinson's Disease.2021; 11(2): 715. CrossRef
Rho‐kinase inhibition by fasudil modulates pre‐synaptic vesicle dynamics
Kim Ann Saal, Carmina Warth Pérez Arias, Anna‐Elisa Roser, Jan Christoph Koch, Mathias Bähr, Silvio O. Rizzoli, Paul Lingor
Journal of Neurochemistry.2021; 157(4): 1052. CrossRef
A Comprehensive Phenotype of Non-motor Impairments and Distribution of Alpha-Synuclein Deposition in Parkinsonism-Induced Mice by a Combination Injection of MPTP and Probenecid
Na-Ra Han, Yu-Kang Kim, Sora Ahn, Tae-Yeon Hwang, Hyejung Lee, Hi-Joon Park
Frontiers in Aging Neuroscience.2021;[Epub] CrossRef
Association of Parkinson’s Disease With Microbes and Microbiological Therapy
Zhao-Ji Chen, Cheng-Yu Liang, Li-Qing Yang, Si-Min Ren, Yan-Min Xia, Lei Cui, Xiao-Fang Li, Bu-Lang Gao
Frontiers in Cellular and Infection Microbiology.2021;[Epub] CrossRef
Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease
Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin
Journal of Parkinson's Disease.2021; 11(3): 1129. CrossRef
The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson’s Disease
Melissa Vos, Christine Klein
Cells.2021; 10(3): 579. CrossRef
Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
Verónica Sambra, Francisca Echeverria, Alfonso Valenzuela, Raphaël Chouinard-Watkins, Rodrigo Valenzuela
Nutrients.2021; 13(3): 986. CrossRef
What substance P might tell us about the prognosis and mechanism of Parkinson's disease?
Paola Tirassa, Tommaso Schirinzi, Marcello Raspa, Massimo Ralli, Antonio Greco, Antonella Polimeni, Roberta Possenti, Nicola Biagio Mercuri, Cinzia Severini
Neuroscience & Biobehavioral Reviews.2021; 131: 899. CrossRef
Baicalein alleviates depression-like behavior in rotenone- induced Parkinson's disease model in mice through activating the BDNF/TrkB/CREB pathway
Xiaoyue Zhao, Dewen Kong, Qimeng Zhou, Guangyi Wei, Junke Song, Yu Liang, Guanhua Du
Biomedicine & Pharmacotherapy.2021; 140: 111556. CrossRef
Apathy and actions- another consideration when theorizing about embodied nature of language in Parkinson's disease
Logan Wolff, Jared F. Benge, Samia Ortiz-Hernandez, Samantha Beevers, Alexandra Armitage, Jungjun Park, Daniel L. Drane
Journal of Communication Disorders.2021; 93: 106144. CrossRef
Association analysis and polygenic risk score evaluation of 38 GWAS-identified Loci in a Chinese population with Parkinson’s disease
Ran Zheng, Song Qiao, Ying Chen, Chongyao Jin, Yi Fang, Zhihao Lin, Naijia Xue, Yiqun Yan, Luyan Gu, Ting Gao, Jun Tian, Yaping Yan, Xinzhen Yin, Jiali Pu, Baorong Zhang
Neuroscience Letters.2021; 762: 136150. CrossRef
Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study
Sara Liguori, Antimo Moretti, Angela Palomba, Marco Paoletta, Francesca Gimigliano, Rosa De Micco, Mattia Siciliano, Alessandro Tessitore, Giovanni Iolascon
NeuroRehabilitation.2021; 49(3): 481. CrossRef
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Qing Wang, Yuqi Luo, K Ray Chaudhuri, Richard Reynolds, Eng-King Tan, Sven Pettersson
Brain.2021; 144(9): 2571. CrossRef
Clinical features contributing to the sit-to-stand transfer in people with Parkinson’s disease: a systematic review
Charmaine Pearl Da Cunha, Pratiksha Tilak Rao, Suruliraj Karthikbabu
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery.2021;[Epub] CrossRef
Integration of Aluminium Interdigitated Electrodes with Zinc Oxide as Nanocomposite for Selectively Detect Alpha-Synuclein for Parkinson’s Disease Diagnosis
Hussaini Adam, Subash C. B Gopinath, Uda Hashim
Journal of Physics: Conference Series.2021; 2129(1): 012094. CrossRef
Effects of depression and exercise on health-related quality of life in patients with Parkinson's disease
George W Koutsouras, Kimberly Levine, Nathalie Duroseau, Christina Ciraco, Vivian Chan, Kathleen Pergament, Thomas Chan, Jayme D Mancini, Adena N Leder, Bhuma Krishnamachari
Chronic Illness.2020; 16(3): 190. CrossRef
Glial Cell Line–Derived Neurotrophic Factor Receptor Rearranged During Transfection Agonist Supports Dopamine Neurons In Vitro and Enhances Dopamine Release In Vivo
Arun Kumar Mahato, Jaakko Kopra, Juho‐Matti Renko, Tanel Visnapuu, Ilari Korhonen, Nita Pulkkinen, Maxim M. Bespalov, Andrii Domanskyi, Eric Ronken, T. Petteri Piepponen, Merja H. Voutilainen, Raimo K. Tuominen, Mati Karelson, Yulia A. Sidorova, Mart Saar
Movement Disorders.2020; 35(2): 245. CrossRef
Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats
Xiao-Jun Feng, Yu-Ting Huang, Ying-Zu Huang, Chi-Wei Kuo, Chih-Wei Peng, Alexander Rotenberg, Chi-Hung Juan, Yu-Cheng Pei, Yuan-Hao Chen, Kai-Yun Chen, Yung-Hsiao Chiang, Hui-Hua Liu, Jian-Xian Wu, Tsung-Hsun Hsieh
Brain Stimulation.2020; 13(3): 655. CrossRef
Dizziness in patients with early stages of Parkinson's disease: Prevalence, clinical characteristics and implications
Kyum‐Yil Kwon, Suyeon Park, Mina Lee, Hyunjin Ju, Kayeong Im, Byung‐Euk Joo, Kyung Bok Lee, Hakjae Roh, Moo‐Young Ahn
Geriatrics & Gerontology International.2020; 20(5): 443. CrossRef
The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease
Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho
Journal of Parkinson's Disease.2020; 10(2): 605. CrossRef
Assessments of plasma acyl-ghrelin levels in Parkinson’s disease patients treated with deep brain stimulation
Wojciech Pietraszko, Agata Furgala, Agnieszka Gorecka-Mazur, Borys Kwinta, Jolanta Kaszuba-Zwoinska, Jaroslaw Polak, Urszula Fiszer, Krzysztof Gil, Anna Krygowska-Wajs
Peptides.2020; 128: 170299. CrossRef
Common and unique connectivity at the interface of motor, neuropsychiatric, and cognitive symptoms in Parkinson's disease: A commonality analysis
Stefan Lang, Zahinoor Ismail, Mekale Kibreab, Iris Kathol, Justyna Sarna, Oury Monchi
Human Brain Mapping.2020; 41(13): 3749. CrossRef
Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases
Dorines Rosario, Jan Boren, Mathias Uhlen, Gordon Proctor, Dag Aarsland, Adil Mardinoglu, Saeed Shoaie
Frontiers in Neuroscience.2020;[Epub] CrossRef
Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila
Iván Fernández-Cruz, Iván Sánchez-Díaz, Verónica Narváez-Padilla, Enrique Reynaud
IBRO Reports.2020; 9: 65. CrossRef
Boxing to Improve Sleep Quality and Daytime Sleepiness in Individuals With Parkinson Disease
Macy Urrutia, Cynthia Ivy, Patricia S. Pohl, Linda Denney
Topics in Geriatric Rehabilitation.2020; 36(3): 170. CrossRef
Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
Vanessa Castelli, Michele d’Angelo, Francesca Lombardi, Margherita Alfonsetti, Andrea Antonosante, Mariano Catanesi, Elisabetta Benedetti, Paola Palumbo, Maria Grazia Cifone, Antonio Giordano, Giovambattista Desideri, Annamaria Cimini
Aging.2020; 12(5): 4641. CrossRef
Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease
Jeong Hoon Park, Seung Hwan Lee, Yeshin Kim, Sang‐Won Park, Gi Hwan Byeon, Jae‐Won Jang
Psychogeriatrics.2020; 20(6): 880. CrossRef
Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson’s disease: a detailed PET analysis of 12 striatal subregions
Soo Bin Park, Kyum-Yil Kwon, Jeong-Yoon Lee, Kayeong Im, Jun-Sang Sunwoo, Kyung Bok Lee, Hakjae Roh, Moo-Young Ahn, Suyeon Park, Soo-Jong Kim, Jungsu S. Oh, Jae Seung Kim
Neurological Sciences.2019; 40(2): 311. CrossRef
Cognitive Problems in Parkinson Disease: Perspectives and Priorities of Patients and Care Partners
Katrina L. Raein, Samia Ortiz-Hernández, Jared F. Benge
Cognitive and Behavioral Neurology.2019; 32(1): 16. CrossRef
Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity
Sunil Srivastav, Sabita Neupane, Sunil Bhurtel, Nikita Katila, Sailesh Maharjan, Hyukjae Choi, Jin Tae Hong, Dong-Young Choi
The Journal of Nutritional Biochemistry.2019; 69: 73. CrossRef
Asymptomatic Hearing Impairment Frequently Occurs in Early-Onset Parkinson’s Disease
Kuldeep Shetty, Syam Krishnan, Jissa Vinoda Thulaseedharan, Manju Mohan, Asha Kishore
Journal of Movement Disorders.2019; 12(2): 84. CrossRef
Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases
Alon Seifan, Christine A. Ganzer, Krista Ryon, Michael Lin, Rahman Mahmudur, Henriquez Adolfo, Cindy Shih, Alan R. Jacobs, Molly Greenwald, Richard S. Isaacson
Current Aging Science.2019; 11(4): 242. CrossRef
Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson’s Disease
Megan C. Bakeberg, Alexa Jefferson, Maddeson Riley, Michelle Byrnes, Soumya Ghosh, Frank L. Mastaglia, Malcom K. Horne, Sarah McGregor, Rick Stell, Jade Kenna, Sue Walters, Dana Hince, Ryan S. Anderton
Parkinson's Disease.2019; 2019: 1. CrossRef
α-Synuclein in Parkinson’s disease: causal or bystander?
Peter Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Classen, Christian Dresel, Wolfgang Jost, Rejko Krüger, Thomas Müller, Heinz Reichmann, Olaf Rieß, Alexander Storch, Sabrina Strobel, Thilo van Eimeren, Hans-Ullrich Völker, Jürgen Winkler,
Journal of Neural Transmission.2019; 126(7): 815. CrossRef
Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson’s Disease
Motoki Okano, Kazue Takahata, Junya Sugimoto, Shizuko Muraoka
Frontiers in Behavioral Neuroscience.2019;[Epub] CrossRef
Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson’s disease
Mi Sun Sung, Seong-Min Choi, Jonghwa Kim, Jun Young Ha, Byeong-Chae Kim, Hwan Heo, Sang Woo Park
Scientific Reports.2019;[Epub] CrossRef
Probiotics for Parkinson’s Disease
Parisa Gazerani
International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
Dongming Yang, Deming Zhao, Syed Zahid Ali Shah, Wei Wu, Mengyu Lai, Xixi Zhang, Jie Li, Zhiling Guan, Huafen Zhao, Wen Li, Hongli Gao, Xiangmei Zhou, Lifeng Yang
Frontiers in Neurology.2019;[Epub] CrossRef
Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson’s Disease
Wan-Ling Tsai, Hsin-Yung Chen, Ying-Zu Huang, Yuan-Hao Chen, Chi-Wei Kuo, Kai-Yun Chen, Tsung-Hsun Hsieh
Behavioural Neurology.2019; 2019: 1. CrossRef
The effectiveness of istradefylline for the treatment of gait deficits and sleepiness in patients with Parkinson’s disease
Keita Matsuura, Hiroyuki Kajikawa, Ken-ichi Tabei, Masayuki Satoh, Hirotaka Kida, Naoko Nakamura, Hidekazu Tomimoto
Neuroscience Letters.2018; 662: 158. CrossRef
Predictors of Mortality in Nondemented Patients With Parkinson Disease: Motor Symptoms Versus Nonmotor Symptoms
D. Santos-García, E. Suárez-Castro, J. Ernandez, I. Expósito-Ruiz, C. Tuñas-Gesto, M. Aneiros-Díaz, T. de Deus-Fonticoba, M. López-Fernández, D. Núñez-Arias
Journal of Geriatric Psychiatry and Neurology.2018; 31(1): 19. CrossRef
Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease
Paula Perez-Pardo, Laus M. Broersen, Tessa Kliest, Nick van Wijk, Amos Attali, Johan Garssen, Aletta D. Kraneveld
Frontiers in Aging Neuroscience.2018;[Epub] CrossRef
Ghrelin and Neurodegenerative Disorders—a Review
Limin Shi, Xixun Du, Hong Jiang, Junxia Xie
Molecular Neurobiology.2017; 54(2): 1144. CrossRef
The neurological effects of ghrelin in brain diseases: Beyond metabolic functions
Qian Jiao, Xixun Du, Yong Li, Bing Gong, Limin Shi, Tingting Tang, Hong Jiang
Neuroscience & Biobehavioral Reviews.2017; 73: 98. CrossRef
First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers
Dale B. Schenk, Martin Koller, Daniel K. Ness, Sue G. Griffith, Michael Grundman, Wagner Zago, Jay Soto, George Atiee, Susanne Ostrowitzki, Gene G. Kinney
Movement Disorders.2017; 32(2): 211. CrossRef
Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
J.‐S. Kim, H.‐E. Park, I.‐S. Park, Y.‐S. Oh, D.‐W. Ryu, I.‐U. Song, Y.‐A. Jung, I. R. Yoo, H.‐S. Choi, P. H. Lee, K.‐S. Lee
European Journal of Neurology.2017; 24(2): 349. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects
Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang
Neurological Sciences.2017; 38(1): 171. CrossRef
Use of monoamine oxidase inhibitors in chronic neurodegeneration
Peter Riederer, Thomas Müller
Expert Opinion on Drug Metabolism & Toxicology.2017; 13(2): 233. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic
Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo
Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Retinal biomarkers provide “insight” into cortical pharmacology and disease
Christine T.O. Nguyen, Flora Hui, Jason Charng, Shajan Velaedan, Anna K. van Koeverden, Jeremiah K.H. Lim, Zheng He, Vickie H.Y. Wong, Algis J. Vingrys, Bang V. Bui, Magnus Ivarsson
Pharmacology & Therapeutics.2017; 175: 151. CrossRef
Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease
Paula Perez-Pardo, Esther M. de Jong, Laus M. Broersen, Nick van Wijk, Amos Attali, Johan Garssen, Aletta D. Kraneveld
Frontiers in Aging Neuroscience.2017;[Epub] CrossRef
DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
Moran Artzi, Einat Even-Sapir, Hedva Lerman Shacham, Avner Thaler, Avi Orr Urterger, Susan Bressman, Karen Marder, Talma Hendler, Nir Giladi, Dafna Ben Bashat, Anat Mirelman, Elisa Greggio
PLOS ONE.2017; 12(4): e0175424. CrossRef
The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies
Paula Perez-Pardo, Tessa Kliest, Hemraj B. Dodiya, Laus M. Broersen, Johan Garssen, Ali Keshavarzian, Aletta D. Kraneveld
European Journal of Pharmacology.2017; 817: 86. CrossRef
Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms
Mayela Rodríguez-Violante, Rosalía Zerón-Martínez, Amin Cervantes-Arriaga, Teresa Corona
Archives of Medical Research.2017; 48(3): 221. CrossRef
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Paula Perez-Pardo, Mitch Hartog, Johan Garssen, Aletta D. Kraneveld
Current Behavioral Neuroscience Reports.2017; 4(4): 361. CrossRef
The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease
Gretchen O. Reynolds, Michael W. Otto, Terry D. Ellis, Alice Cronin‐Golomb
Movement Disorders.2016; 31(1): 23. CrossRef
Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder
Joong-Seok Kim, Hyung-Eun Park, Yoon-Sang Oh, Si-Hoon Lee, Jeong-Wook Park, Byung-chul Son, Kwang-Soo Lee
Journal of the Neurological Sciences.2016; 362: 59. CrossRef
Relearning of Writing Skills in Parkinson's Disease After Intensive Amplitude Training
Evelien Nackaerts, Elke Heremans, Griet Vervoort, Bouwien C.M. Smits‐Engelsman, Stephan P. Swinnen, Wim Vandenberghe, Bruno Bergmans, Alice Nieuwboer
Movement Disorders.2016; 31(8): 1209. CrossRef
Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson’s Disease
Joong-Seok Kim, Si-Hoon Lee, Yoon-Sang Oh, Jeong-Wook Park, Jae-Young An, Sung-Kyung Park, Si-Ryung Han, Kwang-Soo Lee
Journal of Movement Disorders.2016; 9(2): 97. CrossRef
The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
Do-Young Kwon, Seong-Beom Koh, Jae Hyeok Lee, Hee Kyung Park, Han-Joon Kim, Hae-Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim, Seong-Min Choi, Ji-Yun Park, Beom S. Jeon, Ji Young Kim, Sun Ju Chung, Chong Sik Lee, Jeong-Ho Park, Tae-Beom
Journal of Clinical Neurology.2016; 12(4): 393. CrossRef
Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease
Esteban Luna, Kelvin C. Luk
FEBS Letters.2015; 589(24PartA): 3749. CrossRef
Differentiated Cells Derived from Fetal Neural Stem Cells Improve Motor Deficits in a Rat Model of Parkinson's Disease
Wei Wang, Hao Song, Aifang Shen, Chao Chen, Yanming Liu, Yabing Dong, Fabin Han
Translational Neuroscience and Clinics.2015; 1(2): 75. CrossRef

Original Article

Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia: Yoon-Sang Oh, Joong-Seok Kim, Phil Hyu Lee; J Mov Disord. 2015;8(2):98-102. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15041

21,704 View
264 Download
27 Web of Science
30 Crossref

Abstract PDF

Objective A recent study showed that rivastigmine and memantin improved behavioral and psychiatric symptoms of dementia (BPSD) in Alzheimer’s dementia. Furthermore, according to recent guidelines presented by the Movement Disorder Society, rivastigmine is efficacious for the treatment of dementia in Parkinson’s disease (PD). We investigated the efficacy of rivastigmine for BPSD in patients with Parkinson’s disease dementia (PDD).
Methods Twenty-three patients in whom cognitive impairment occurred at least one year after a diagnosis of PD participated in this open-label trial. Cognitive, psychiatric, and motor symptoms were assessed before and after 24 weeks of treatment with rivastigmine using unstructured clinical assessments and rating scales including the Unified Parkinson’s Disease Rating Scale, Mini-Mental State Examination (MMSE), and the Neuropsychiatric Inventory.
Results Age (± standard deviation) was 74.7 ± 5.9 years, average duration of PD was 3.5 ± 3.7 years, Hoehn and Yahr scores were 2.2 ± 0.8, and baseline MMSE scores were 19.1 ± 4.2. Improvements in global mental symptoms and neuropsychiatric symptoms were significant; among them, hallucination, depression and appetite changes improved. Caregiver distress significantly decreased, including distress resulting from hallucinations, depression, apathy, and appetite changes.
Conclusions Although controlled trials are required, the findings suggest that rivastigmine is useful for control of several neuropsychiatric symptoms and beneficial for caregiver distress in patients with PDD.

Citations

Citations to this article as recorded by

The treatment of behavioural and psychological symptoms in dementia: pragmatic recommendations
Camille Mercier, Victoria Rollason, Mohamed Eshmawey, Aline Mendes, Giovanni B. Frisoni
Psychogeriatrics.2024; 24(4): 968. CrossRef
Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, Anastasia Bougea, Dionysia Kontaxopoulou, Stella Fragkiadaki, Christos Koros, Vasiliki Epameinondas Georgakopoulou, George Fotakopoulos, Yiannis Koutedakis, Christina Piperi, Sokratis
Medicina.2023; 59(8): 1454. CrossRef
Treatment of Alzheimer’s disease
Aleksandra Klimkowicz-Mrowiec
Aktualności Neurologiczne.2023; 23(4): 145. CrossRef
Parkinsonism and dementia
Christos Koros, Leonidas Stefanis, Nikolaos Scarmeas
Journal of the Neurological Sciences.2022; 433: 120015. CrossRef
Current concepts in treating mild cognitive impairment in Parkinson's disease
Jay S. Schneider, Sandhya Kortagere
Neuropharmacology.2022; 203: 108880. CrossRef
Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
Ségolène De Waele, Patrick Cras, David Crosiers
Brain Sciences.2022; 12(7): 923. CrossRef
Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
Łucja Justyna Walczak-Nowicka, Mariola Herbet
International Journal of Molecular Sciences.2021; 22(17): 9290. CrossRef
Diagnosis and treatment of old-onset Parkinson's disease
久大立花
Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics.2021; 58(3): 341. CrossRef
Neuropsychiatrische Störungen bei idiopathischem Parkinson-Syndrom
Mario Paulig
Nervenheilkunde.2021; 40(10): 752. CrossRef
Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
Katie Pizzolato, David Thacker, Nicole Del Toro-Pagán, Abeer Hanna, Jacques Turgeon, Adriana Matos, Nishita Amin, Veronique Michaud
Medicina.2021; 57(10): 1107. CrossRef
Effectiveness of clozapine, oxcarbazepine and rivastigmine combination in a bipolar disorder patient with initial cerebral atrophy
Paolo Morana, Federico Mucci, Stefano Baroni, Alessandra Della Vecchia, Armando Piccinni, Benedetto Morana, Donatella Marazziti
Clinical Case Reports.2020; 8(2): 254. CrossRef
Neuropsychiatric Disorders in Parkinson’s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?
Kathy Dujardin, Véronique Sgambato
Frontiers in Neuroscience.2020;[Epub] CrossRef
Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson’s Disease, and Multiple Sclerosis: Diagnosis and Treatment
Susan K. Conroy, Katherine B. Brownlowe, Thomas W. McAllister
Focus.2020; 18(2): 150. CrossRef
Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice
Claudia Lazcano-Ocampo, Yi Min Wan, Daniel J van Wamelen, Lucia Batzu, Iro Boura, Nataliya Titova, Valentina Leta, Mubasher Qamar, Pablo Martinez-Martin, K Ray Chaudhuri
Expert Review of Neurotherapeutics.2020; 20(5): 477. CrossRef
Diagnosis, treatment and management of apathy in Parkinson’s disease: a scoping review
Bria Mele, Shinia Van, Jayna Holroyd-Leduc, Zahinoor Ismail, Tamara Pringsheim, Zahra Goodarzi
BMJ Open.2020; 10(9): e037632. CrossRef
Pharmacological treatment of apathy in Lewy body disorders: A systematic review
Jennifer Liu, Christine A. Cooper, Daniel Weintraub, Nabila Dahodwala
Parkinsonism & Related Disorders.2019; 60: 14. CrossRef
Current treatment of behavioral and cognitive symptoms of Parkinson's disease
Irena Rektorova
Parkinsonism & Related Disorders.2019; 59: 65. CrossRef
Approach to the management of psychosis in Parkinson’s disease
Abhishek Lenka, Vasanthi Gomathinayagam, Laxman Bahroo
Annals of Movement Disorders.2019; 2(3): 83. CrossRef
Risk factors for non-motor symptoms in Parkinson's disease
Johan Marinus, Kangdi Zhu, Connie Marras, Dag Aarsland, Jacobus J van Hilten
The Lancet Neurology.2018; 17(6): 559. CrossRef
The efficacy of pharmacological approaches to therapy of the apathy syndrome in dementia disorders (the review)
A. S. Avedisova, A. B. Guekht, K. V. Zakharova, R. G. Akzhigitov
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2018; 118(4): 126. CrossRef
Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle
Rita Moretti, Paola Caruso, Matteo Dal Ben
Parkinson's Disease.2017; 2017: 1. CrossRef
Caregiver Burden in Parkinson Disease: A Critical Review of Recent Literature
Philip E. Mosley, Rebecca Moodie, Nadeeka Dissanayaka
Journal of Geriatric Psychiatry and Neurology.2017; 30(5): 235. CrossRef
Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson’s Disease: Implication for Treatment
Stephane Thobois, Stephane Prange, Véronique Sgambato-Faure, Léon Tremblay, Emmanuel Broussolle
Current Neurology and Neuroscience Reports.2017;[Epub] CrossRef
Parkinson’s Disease Psychosis: Presentation, Diagnosis and Management
Ruth B Schneider, Julia Iourinets, Irene H Richard
Neurodegenerative Disease Management.2017; 7(6): 365. CrossRef
Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson’s Disease
Yunlong Zhang, Feng Tan, Pingyi Xu, Shaogang Qu
Neural Plasticity.2016; 2016: 1. CrossRef
Neuropsychiatric Issues in Parkinson’s Disease
Jeffrey W. Cooney, Mark Stacy
Current Neurology and Neuroscience Reports.2016;[Epub] CrossRef
Parkinson’s Disease Psychosis: Therapy Tips and the Importance of Communication Between Neurologists and Psychiatrists
Daniel Martinez-Ramirez, Michael S Okun, Michael S Jaffee
Neurodegenerative Disease Management.2016; 6(4): 319. CrossRef
Pimavanserin for the treatment of Parkinson’s disease psychosis
Ines Chendo, Joaquim J Ferreira
Expert Opinion on Pharmacotherapy.2016; 17(15): 2115. CrossRef
Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments
Fleur Harrison, Liesbeth Aerts, Henry Brodaty
Current Psychiatry Reports.2016;[Epub] CrossRef
Pharmacotherapies for Parkinson’s disease symptoms related to cholinergic degeneration
Santiago Perez-Lloret, María Cecilia Peralta, Francisco J. Barrantes
Expert Opinion on Pharmacotherapy.2016; 17(18): 2405. CrossRef

Letters to the editor

Two Cases of Secondary Hemifacial Spasm: Pathophysiology and Management: Frederick A. Zeiler, Anthony M. Kaufmann; J Mov Disord. 2015;8(2):103-105. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15004

12,259 View
88 Download
3 Web of Science
1 Crossref

PDF

Citations

Citations to this article as recorded by

A Case Report of Hemifacial Spasm Caused by Vestibular Schwannoma and Literature Review
Xiaomin Cai, Yinda Tang, Hua Zhao, Zheng Chen, Haopeng Wang, Wanchun Zhu, Shiting Li
Brain Sciences.2022; 12(10): 1347. CrossRef

Parkinsonism and Dementia Associated with Giant Virchow-Robin Spaces: Myung Sik Lee, Cheol Hyung Lyoo, Tae Sub Chung; J Mov Disord. 2015;8(2):106-107. Published online May 31, 2015; DOI: https://doi.org/10.14802/jmd.15013

13,163 View
82 Download
6 Web of Science
10 Crossref

PDF

Citations

Citations to this article as recorded by

Food for Thought: A Review of Neuroradiographic Signs Inspired by Food
C.T. Zoppo, T. Taros, J. Singh, A.S. Puri, A.L. Kuhn
Neurographics.2024; 14(1): 29. CrossRef
Espacios de Virchow-Robin mesencefálicos y parkinsonismo: caso clínico y revisión de la literatura
M.O. Iridoy, P. Clavero, T. Cabada, M.E. Erro
Neurología.2021; 36(2): 171. CrossRef
Midbrain Virchow-Robin spaces and Parkinsonism: A case report and literature review
M.O. Iridoy, P. Clavero, T. Cabada, M.E. Erro
Neurología (English Edition).2021; 36(2): 171. CrossRef
Cognitive impairment due to widespread enlarged perivascular spaces
Yoshitaka Yamaguchi, Manabu Wada, Luna Kimihira, Hikaru Nagasawa
Radiology Case Reports.2021; 16(9): 2640. CrossRef
Aberrant Neurogliovascular Unit Dynamics in Cerebral Small Vessel Disease: A Rheological Clue to Vascular Parkinsonism
Che Mohd Nasril Che Mohd Nassir, Thenmoly Damodaran, Siti R. Yusof, Anwar Norazit, Geetha Chilla, Isaac Huen, Bhanu Prakash K. N., Norlinah Mohamed Ibrahim, Muzaimi Mustapha
Pharmaceutics.2021; 13(8): 1207. CrossRef
Perivascular Unit: This Must Be the Place. The Anatomical Crossroad Between the Immune, Vascular and Nervous System
Fernanda Troili, Virginia Cipollini, Marco Moci, Emanuele Morena, Miklos Palotai, Virginia Rinaldi, Carmela Romano, Giovanni Ristori, Franco Giubilei, Marco Salvetti, Francesco Orzi, Charles R. G. Guttmann, Michele Cavallari
Frontiers in Neuroanatomy.2020;[Epub] CrossRef
Tumefactive Virchow-Robin spaces
Robert M. Kwee, Thomas C. Kwee
European Journal of Radiology.2019; 111: 21. CrossRef
Dilated Virchow-Robin space and Parkinson's disease: A case report of combined MRI and diffusion tensor imaging
Renata Conforti, Angela Sardaro, Alberto Negro, Giuseppina Caiazzo, Antonella Paccone, Rosita De Micco, Sossio Cirillo, Alessandro Tessitore
Radiology Case Reports.2018; 13(4): 871. CrossRef
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis
Alice Favaretto, Andrea Lazzarotto, Alice Riccardi, Stefano Pravato, Monica Margoni, Francesco Causin, Maria Giulia Anglani, Dario Seppi, Davide Poggiali, Paolo Gallo, Dzung Pham
PLOS ONE.2017; 12(10): e0185626. CrossRef
Movement Disorders Following Cerebrovascular Lesions: Etiology, Treatment Options and Prognosis
Do-Young Kwon
Journal of Movement Disorders.2016; 9(2): 63. CrossRef

First
Prev
Page of 1
Next
Last

Previous issues